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VIRUS-ASSOCIATED CELL SURFACE
PRODUCTS: RELEVANCE TO MALIG-
NANT TRANSFORMATION. J. WYKE,
ICRF, London.
Infection by viruses of several different
families is associated with neoplasia, and
many instances are known in which products
associated with these viruses are situated at
the surface of both normal and malignant
cells. It has proved difficult to link these
virus-specific cell-surface molecules with
either the cause or the progression of malig-
nancy. For this reason we will consider in
basic terms the possible mechanisms of virus-
induced transformation, and the role that
virus-associated cell-surface components may
play in such events, and we will attempt to
assess the relevance of known virus-specific
changes within this framework.
Cells may become transformed by viruses
whose life cycle is lytic as well as by non-
lytic agents. In the former case the cell sur-
vives, either because it is non-permissive or
semi-permissiveforvirusreplicationorbecause
virus replication is defective. In the latter in-
stancesimilar constraints mayreducethe level
ofvirusexpression, butitisalsopossibleforthe
transformed cell to yield fully infectious virus.
Whatever the nature ofvirus-cell interaction,
the transformed cell always carries virus
genetic material, and viruses could thus trans-
form by interfering with normal cell controls
in several ways. Firstly, integrated viral
DNA may disrupt regulated expression ofthe
cell genome, a situation which does not re-
quire the expression of viral genes. Secondly,
virus-coded products may mimic the effect,
or even the detailed action, of cell growth-
promoting stimuli. If the virus-specific mole-
cules are located in or near the cell membrane
they may mimic exogenous signals acting
across the cell surface, but the viral products
may also resemble endogenous signals for
growth.
Such virus-coded or virus-specific growth-
promoting stimuli could be (1) structural pro-
teins of the virus or their precursors (in their
native form ormodified bymutation, recombi-
nation or aberrant processing in an unusual
host), (2) non-structural proteins involved in
virus replication (which may also undergo
modification), or (3) non-structural proteins
with no apparent function in the virus life
cycle. The latter class of potential transform-
ing proteins may be particularly important in
the Retroviridae, whose mode of replication
andhigh rateofgenetic recombination make it
likely that the virus can acquire, by recom-
bination, a new genetic material from either
the host or another virus. The new material
may comprise a clearly defined cistron, dis-
tinct from viral replicative functions, or it
may be part of a hybrid gene (derived by re-
combination within a viral cistron) which
codes for a protein with some amino acids in
common with a virus protein and others of
foreign origin. If retroviruses recombine with
one another, the viral replicative functions
could also be altered, and some oncogenic
viruses seem to arise by recombination
between two non-oncogenic parents.
Only two virus genes have been shown, by
reasonable genetic and biochemical criteria,
to be involved in causing cell transformation;
the early region (T-antigen complex) of
papovaviruses and the src gene of sarcoma-
inducing retroviruses. It is possible that the
proteins encoded in these genes may have
similar mechanisms for inducing cell trans-
formation but, whereas the papovavirus-
coded proteins are involved in virus replica-
tion, the src gene product seems unrelated to
the virus life cycle and this gene is possibly of
host-cell origin. The cellular location of these
proteins and their detailed mode of action is
not understood, and it is possible that they
may show functional polymorphism. One
component of the T-antigen complex is
membrane associated (though not known to
be on the cell surface) and the expression of
both the papovavirus and the retrovirus
genes in the cell is closely correlated with the
presence of virus-specific tumour antigens on
the cell surface. However, the relationship
between these antigens and the viral trans-
forming genes is not understood.
Another group of retroviruses, typified by
the erythroblastosis and myelocytoma viruses
of chickens and the Abelson leukaemia virus
ofmice, arereplication-defective agents which
all encode a protein which comprises a portion
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of the retrovirus gag gene and amino acid
sequences of an unknown origin. For some
of these viruses there is preliminary genetic
evidence that these hybrid proteins may be a
cause ofcell transformation, but their location
in the infected cell is as yet unknown.
In the case of other leukaemia-inducing
retroviruses there is no clear evidence for the
involvement of a virus gene in the main-
tenance of the transformed state, but there is
ample documentation ofthe presence ofvirus-
associated antigens on the leukaemic cell
surface. Some of these antigens, such as the
mouse Glx thymocyte antigen and Gross cell-
surface antigen (GCSA) were known to be
associated with leukaemia-virus-induced neo-
plasms, but were thought possibly to be of
non-viral origin. However, it is now known
that Glx antigenicity is carried on the murine
leukaemic virus (MuLV) envelope glycopro-
tein, whilst GCSA represents glycosylated
forms of the precursors to the internal pro-
teins of MuLV encoded by the viral gag gene.
With increasing awareness of endogenous
virus-specific proteins, including the env and
gag gene products, in normal as well as trans-
formed cells, it is difficult to assign to these
antigens a function in the causation of
leukaemia It is possible that they are simply
evidence of viral gene activity, which may be
a prerequisite for leukaemogenesis but which
may also be apparent in other stages in the
life of the host. However, though we do not
know whether the virus antigens on the sur-
face of the leukaemic cells have a causal role
in the neoplasm, they, like the surface tumour
antigens associated with sarcoma viruses, are
invariably present. If this novel antigenicity
elicits an immune response from the host, the
virus-associated surfaceproteins maybe anim-
portant factor inthe progression ofthe disease.
CELL-SURFACE PROPERTIES,
GROWTH AND MALIGNANCY OF
HAEMOPOIETIC CELL LINES. K. NILS-
SON, The Wallenberg Laboratory, University of
Uppsala, Sweden.
During the last few years, improved tissue-
culture methodology has allowed the estab-
lishment of a number of cell lines in vitro from
both normal and neoplastic human haemo-
poietic tissue and peripheral blood. Analyses
of the phenotypic characteristics of haemo-
poietic lines have revealed that most of them
are polyclonal and normal diploid in early
passages, carry Epstein-Barr virus (EBV) and
are therefore derived from presumably non-
neoplastic precursor cells. Such cell lines,
tentatively termed lymphoblastoid, can be
established wi,ith ease from any anti-EBV7
seropositive individual. In contrast, truly
neoplastic haemopoietic cell lines (leukaemia,
lymphoma, myeloma) are still rare, and have
been established only with great difficulty.
The neoplastic lines are always monoclonal,
aneuploid and, with exception for Burkitt's
lymphoma lines, EBV-genome negative.
The lymphoblastoid lines (LCL) have a
lymphoblastoid morphology, produce im-
munoglobulin (Ig) and express lymphocyte
surface markers indicating a B-cell descent.
The LCLs gradually evolve towards mono-
clonality and aneuploidy during continuous
cultivation. This in vitro selection of an
aneuploid clone usually occurs within one
year of serial passage.
From the studies with the group of malig-
nant haemopoietic lines a few general con-
clusions seem justified. Firstly, all the lines
have individually distinct properties, suggest-
ing that each human haemopoietic tumour,
although sharing some basic morphological
and functional features with other tumours
belonging to the same histopathological
entity, is unique. Secondly, haemopoietic
tumours continue to express most of the
features of the corresponding normal cells.
Thirdly, the expression of the phenotypic
properties is usually stable during at least
1-2 years of continuous cultivation in vitro.
The leukaemic-cell lines are most frequently
lymphoblastoid in morphology and usually
have a T-cell-like phenotype. A few cell lines
have surface characteristics indicating a
non-T, non-B lymphocyte origin; even fewer
lines have a suggestive B-cell origin. Recently,
the first leukaemic cell line with myeloid
characteristics has been established from a
myeloid leukaemia. To date, 3 myeloma lines
and 3 lymphocytic lymphoma lines have been
reported. The myeloma lines express plasma-
cell surface characteristics while the lympho-
cytic lymphoma lines have a B-cell pheno-
type. The largest number of lymphoma lines
has been established from diffuse histiocytic
lymphoma. The phenotypic variability among
these lines is suggestive of a marked hetero-
geneity with respect to cell type of origin in
tumours classified histologically as "histio-
cytic". The majority produce Ig, and thus
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seem to be derived from the B-lymphocyte
series. Some lines have a lymphocyte morph-
ology but express no lymphocyte surface
inarkers, and have therefore tentatively been
classified as being derived from non-T, non-B
lymphocytes. Three lines have morphological,
lymphocyte surface marker and enzyme
characteristics, indicating descent from a
monocyte type of cell, and would thus repre-
sent truly histiocytic lymphomas.
The aimn of this overview is to describe
some of our recent studies on cell-surface
characteristics of malignant haemopoietic
cell lines, with special reference to pheno-
typic properties assumed to be related to the
neoplastic state of the cells. The main results
wNill be briefly summarised in the following:
(1) Exposed surface glycoproteins (GP)
have been studied in a panel of neoplastic
(lymphoma, leukaemia, myeloma) and non-
neoplastic (LCL) lines by the galactose
oxidase-tritiated sodium borohydride label-
ling technique. The labelled GPs were
separated by polyacrylamide slab-gel electro-
phoresis and visualized by autoradiography.
Each type ofmalignant haemopoietic cell line
was found to have a basic, easily distinguish-
able surface GP pattern. In addition, each
line had one or a few unique GPs. The B and
T lines had most GPs in common with normal
B and T cells, respectively. The GPs most
constantly associated with malignancy were
found in B lymphomas as double bands with
apparent mol. wts of 85-87 and 69-71. The
nature of these GPs has not as yet been
clarified. In leukaemia and myeloma lines,
only unqiue GPs were found in addition to
those shared with normnal cells. In the group
of histiocytic lymphoma lines 4 types of GP
patterns could be distinguished: (a) a basic-
ally B-lymphocyte-like pattern in 2 lines ex-
pressing B-cell surface markers; (b) a basic-
ally T-lymphocyte-like pattern in 1 line with
non-T, non-B surface phenotype; (c) a
basically monocyte-like pattern in 1 line with
a monocyte-like phenotype: (d) a 'stem"
cell-like pattern in 2 other lines with a
histiocyte-like phenotype. The surface-label-
ling technique thus seems to be useful in
discriminating the different types of "histio-
cytic" lymphomas.
(2) The fucose-labelled GPs of the haemo-
poietic lines were also characterized by gel
filtration after degradation and release from
the cell surface by proteolytic enzymes. The
results demonstrate that the tumour lines,
almost wAithout exception, contain an in-
creased amount of fast-eluting glycopeptides
than a larger normal cell. Such fast-eluting
glycopeptides have previously been demon-
strated in several animals and human
tumours, but not in normal cells. Interest-
ingly, the surface glycopeptides of the LCL
type oflines also had this "malignant" elution
profile.
(3) The binding of the lectin Helix pomatia
agglutinin (HP) to the surface of the various
types of cell lines has been studied. In T lines
a selective binding to a GP with an apparent
mol. wt of 150 ku was found, whilst in B
lymphoma and myeloma lines this lectin
bound to a 210 GP. The non-T, non-B
leukaemias bound HP to a 150 ku GP. The
group of histiocytic lymphoma lines was
again heterogeneous. The 2 Ig+ lines expressed
a 210 ku HP-binding surface GP, whilst the
line with a non-T, non-B phenotype bound
HP to a 150 ku GP. The 3 lines with a
monocytic phenotype could be subdivided
into 2 subgroups with respect to HP binding.
The lysozyme-secreting U-937 line did not
bind HP, whilst the 2 other lines had 3 HP-
binding GPs of210 ku, 150 ku and 70 ku. The
HP studies confirm that the group of rare,
truly histiocytic lymphomas also seems to be
heterogeneous, and that such lymphomas
may be derived from various stages of mono-
cyte (histiocyte) differentiation.
(4) Employing a panel ofantisera (NIH) to
C-type virus-associated surface antigens in a
screening by the staphylococcal protein A
radioimmunoassay, most lines, including the
many Burkitt's-lymphoma lines, were found
to be negative. However, a few other lymph-
oma lines and one myeloma line reacted with
anti-p30 and anti-GP70 ku.
(5) The tumorigenicity of the haemopoietic
lines has been extensively studied by inocula-
tion tests in nude mice. When inoculated s.c.,
most but not all neoplastic lines formed
tumours, whilst the EBV-carrying diploid
LCLs failed to grow. However, using the
intracranial route, both the diploid LCL and
the neoplastic lines grew. The implications of
these results in relation to the putative
oncogenic role of EBV will be discussed.
GLYCOLIPIDS AND MALIGNANCY; A
REVIEW OF SOME CURRENT IDEAS.
D. R. CRITCHLEY, Department ofBiochemistry,
University of Leicester, Leicester.
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Experimental evidence has confirmed the
hypothesis that changes in cell-surface
organization are associated with the malig-
nant cell.1 One such change is loss ofthe more
complex glycolipids from the malignant-cell
surface, a consistent observation, whether the
malignant cells are derived by viral or
chemical transformation of stable cell lines or
from spontaneously occurring or induced
tumours (reference 2 for a review%N). The
potential importance of the change has re-
cently been emphasized by the demonstration
that glycolipids can act as membrane recep-
tors for a number of proteins, some of which
in turn are able to influence intracellular
events through elevation of cAMP levels.
Current evidence suggests that several bac-
terial toxins (e.g. cholera3'4 and tetanus
toxins5), the glycoprotein hormones (thyro-
tropin (TSH).6'7 luteinizing hormone (LH),8
and human clhorionic gonadotropin (HCG)9),
and interferon'0"'1 are all able to recognize
specific carbohydrate sequences contained in
glycolipids. Interestingly, the structure of
cholera toxin has certain similarities with that
of the glycoprotein hormones.6"12
Of the above examples, the interaction
between cholera toxin and its putative re-
ceptor, glycolipid GM, (Table) lhas been the
most extensively studied.
(a) Binding of toxin to target cells is
abolished by pre-incubating the toxin with
GM, (20 ng/ml), other glycolipids lacking the
terminal galactose residue (e.g. GM2, GDla and
GM3) being much less effective inhibitors.3
(b) Cells lacking GM, do not bind orrespond
to cholera toxin, but can be made toxin
responsive by incorporating exogenous GM,
into their membrane.13"14
(e) Liposomes containing GM, bind cholera
toxin.15
(d) Saturating levels of toxin protect the
terminal galactose residue of GM, from
galactose oxidase.4'7
(e) GM, (and the oligosaceharide derived
from it) but not GM2 or GM3, causes a "blue-
shift" in the fluorescence spectrum of the
toxin, suggesting that the interaction leads to
a conformational change in the toxin.7'16
We have recently extended these observa-
tions by showing that GM, is the only glyco-
lipid recovered when intact surface-labelled
(galactose oxidase or periodate/borotritiide'7)
BALB or Swiss 3T3 cells are exposed to toxin,
and the toxin-receptor complexes isolated
from NP40 extracts ofthe cells by addition of
anti-toxin followed by formalin-treated
Staphylococcus aureus.18 Glycolipids GM3 and
GDla, the major cellular glycolipids and the
ones most strongly labelled by the periodate
procedure, were not recovered bv this method
(Critchley & Ansell, unpublished data).
Evidence that glycolipids are part of the
glycoprotein hormone-receptor system stems
largely from the follo-wing observations:
(a) Glycolipids inhibit hormone binding,
each hormone having a distinctive glycolipid
inhibition profile6'8'9 (Table). A detailed
examination of the glycolipids of the thyroid
TABLE- The relative potencies ofvarious glyco-
lipids* in inhibiting toxin or hormone binding
to target tissues.
CT GM»>>GDla>GM2>GT»>>GM3 (3)
Tetanus GDlb
= GT1 >GM1 >GDia>GM2(5)
TSH GDIb>GT1>GM,>GM2= GM3>GDla(6)
HCG GT1>GDia>GD1b>GM2>GM1(9)
LH GT1>GDJb> >GDla>GMi>GM2(8)
FSH dlata not available
*GM3=Cer-GIc-Gal-NAN;
GM2=Cer-Glc-Gal(NAN) GalNAc;
GM1 =Cer-Glc-Gal(NAN)-GaINAc-Gal;
GD1a=Cer-Glc-Gal(NAN) GaINAc-Gal(NAN);
GD1b=Cer-Glc-Gal(NAN-NAN) GalNAc-Gal;
GT1=Cer-Glc-Gal(NAN-NAN) GalNAc-Gal(NAN).
Abbreviations: Cer, ceramide; Glc, glucose; Gal,
galactose; CalNAc, N-acetylgalactosamine; NAN,
N-acetylneuraminic acid.
have resolved at least 28 sialic acid-containing
glycolipids, one of which is markedly better
at inhibiting TSH binding to thyroid mem-
branes than the previous best inhibitor
GDib.19 The molecule, wrhich has yet to be
fully characterized, is a minor component of
the total membrane glycolipid (0-015% of the
total lipid-bound sialic acid; 104 molecules
per cell). Other glycolipids, e.g. minor com-
ponents of testicular membranes, may well
act as the in vivo receptors for HCG and LH.
(b) The change in the fluorescence spectrum
of the hormone induced by the glycolipid
which is the best inhibitor of binding is
distinct from that produced by a minimal
inhibitor of binding.6,8,9
(c) Also in support of the above data is the
finding that the target tissues for TSH and
HCG have unusually high levels of the
more complex glycolipids for extraneural
tissues.6,8,9,19,20
Initially these results appear surprising, in
that glycoprotein receptors for TSH and
461462 I.C.R.F. AND B.A.C.R. JOINT SYMPOSIUM
HCG have previously been isolated.21'22
However, the primary determinant of the
hormone-receptor interaction is probably a
specific carbohydrate sequence, and it is not
without precedent for the same carbohydrate
sequence to appear in both glycolipid and
glycoprotein.23'24 Membranes from a thyroid
tumour which is unresponsive to TSH not
only lack the glycoprotein receptor, but levels
of the more complex glycolipids are also
markedly reduced.25 In the light of the
possible dual nature of the glycoprotein-
hormone receptors, it is conceivable that a
glycoprotein receptor for cholera toxin re-
mains to be discovered.
However, some doubt about the role of
glycolipids as the primary receptor for the
glycoprotein hormones still remains, stem-
ming from the observation that, whilst in-
jection of HCG into rats leads to a reduction
in HCG binding by testicular membranes, the
glycolipid profile of the membranes is un-
altered.20 In addition, glycolipids extracted
from the testes of treated rats were as effec-
tive as those from control animals in inhibit-
ing 1251-HCG binding by isolated testicular
membranes. Similar questions are posed by
the finding that whilst thyroid cells from
patients with Grave's disease bind normal
amounts of TSH, the glycolipid profile of the
cells is altered.26 It would be interesting to
re-examine the glycolipid profile ofthese cells
in the light of the more recent data showing
that the putative glycolipid receptor for TSH
is a very minor component ofthe thyroid cell
membrane.19
Given that glycolipids are candidate mem-
brane receptors for certain hormones, their
loss from the tumour-cell surface may well
place the cells outside the sphere of influence
ofthose mechanisms which normally regulate
the expression of certain of the differentiated
cellular functions. An additional role for
glycolipids in cell-cell-interaction has been
proposed.27 Recent evidence suggests that
glycolipids are important cell-surface deter-
minants in retinotectal adhesion28 and nerve-
muscle interaction.29 Clearly, were these
observations confirmed and extended, loss of
cell-surface glycolipids might be an important
factor in the breakdown in cellular inter-
action characteristic of malignant cells.2
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CELL-SURFACE PROTEINS AND THE
TRANSFORMED PHENOTYPE. R.
HYNES, Dept. ofBiology and Centerfor Cancer
Research, M.I.T., Cambridge, Mass., U.S.A.
A variety of phenotypic properties of
oncogenically transformed cells involve cell-ABSTRACTS OF INVITED CONTRIBUTIONS
surface proteins. Thus, cellular growth con-
trol may operate through cell-cell contact or
through the binding of hormones or growth
factors to cell-surface receptors. Growth con-
trol is altered by transformation and, which-
ever control mechanism operates is likely to
involve surface proteins. Cellular adhesion
and a complex of related properties (morph-
ology, cytoskeleton, migration, contact in-
hibition of movement) are also frequently
altered by malignant transformation. Finally,
tumour cells bear neoantigens against which
immune responses are mounted. For all these
reasons it is reasonable to inquire into altera-
tions in cell-surface proteins.
During the past several years a number of
alterations in surface and membrane pro-
teins have been described.1 The challenge is
to determine which of these changes, if any,
are involved in the altered phenotype of
transformed cells.
One protein has been particularly exten-
sively studied. It is a large glycoprotein of
subunit mol. wt 210-250 ku and is commonly
known as LETS protein or fibronectin. Fibro-
nectin is a major surface protein of fibro-
blasts, and also occurs on some other cell
types (myoblasts, endothelial cells, amniotic
cells, some epithelial cells in culture, and
maybe others). It is not a typical membrane
protein and depending on one's point of view
it can be considered as a peripheral or ex-
trinsic membrane protein, as a constituent of
the cell-surface coat, or as part of the extra-
cellular matrix. A fraction rich in fibronectin
but containing little or no lipid can be
separated from plasma membranes.4'5 This
fraction appears to be the cell-surface coat
and contains a variety ofother glycoproteins.
Immunofluorescence studies show that fibro-
nectin occurs in fibrillar networks under, over
and between cells.6 9 The exact pattern
depends on the cell type and the culture con-
ditions.
The properties of cell-surface fibronectin
(LETS protein) which make it of interest in
the context of oncogenic transformation are
that it is regulated in amount in normal cells,
depending on their density and state of
growth10, and that it is absent or greatly
reduced in most transformed cells. The corre-
lation between transformation or tumori-
genicity and loss of fibronectin is good, but
not perfect."3"12"13 Exceptions can be found.
However, in cells transformed by tumour
viruses temperature-sensitive for transforma-
tion, loss of fibronectin is also temperature-
sensitive as expected for a property closely
linked with the transformed phenotype.
The reasons for the reduced levels of fibro-
nectin on transformed cells are not yet fully
understood. Part of the explanation lies in a
reduced level of synthesis, but this is not a
sufficient explanation.'7"18 Normal cells also
regulate their rate of biosynthesis, growing
cells synthesizing fibronectin at a lower rate
than growth-arrested ones19. This appears to
be a sufficient explanation for the reduced
levels on normal growNing cells and may be the
reason for the reduced rate of synthesis in
transformed cells which are, naturally, grow-
ing. However, there is a depression in surface
levels over and above this effect. Transformed
cells also bind fibronectin less well than
normal cells.19,20 Attempts to explain the loss
of fibronectin, which is extremely sensitive to
proteases, as a consequence of activation of
plasminogen by plasminogen activator pro-
duced by transformed cells, have led to the
conclusions that plasminogen activation is
neither necessary nor sufficient, and that
proteolysis of fibronectin is an unlikely ex-
planation for its absence.13'2'-3: It remains
possible that some other molecule to which
fibronectin binds is either absent in trans-
formed cells or is degraded by proteolysis.
To determine which aspects of the trans-
formed phenotype might be related to the
absence of fibronectin, the protein can be
purified from normal cells and added to trans-
formed cultures.24'25 The added fibronectin
binds to the transformed cells in a fibrillar
network very similar to that on normal
cells.25 The transformed cells show increased
cell-substratum attachment and spreading.
and reduced cell overlapping. With increasing
doses, the cells become elongated and aligned
like normal fibroblasts. All ofthese effects can
be viewed as consequences of increased ad-
hesion mediated by the added fibronectin. It
now appears that contact inhibition of move-
ment is a consequence of adhesion between
cells and substratum, which is reduced in
transformed cells.26 Thus, one can hypo-
thesize that addition of fibronectin produces
increased adhesion and decreased cell over-
or underlapping, leading to contact inhibition
of movement and cell alignment. The
corollary of this hypothesis is that reduced
levels of fibronectin in transformed cells lead
to reduced adhesion, and that several other
parameters of the transformed phenotype
463464 I.C.R.F. AND B.A.C.R. JOINT SYMPOSIUM
(rounded morphology, surface ruffles, loss of
contact, inhibition of movement, overlapping
and multilayering) follow from this. It has
also been shown that exogenously added
fibronectin increases cell spreading and
migration in normal cells.27 These results
conform with the observation by immuno-
fluorescence microscopy that fibronectin is
arrayed in characteristic fibrillar patterns
beneath the spreading lamellae of spreading
or migrating cells.19
Another parameter of transformation
which may or may not be related to cellular
adhesion and morphology is the apparent
disorganization ofthe microfilamentous arrays
in transformed cells. Normal cells possess
actin microfilaments arrayed in submem-
branous sheaths and in bundles traversing
the cell. Electron and immunofluorescent
microscopy have shown that these arrays
are less well-developed in most trans-
formed cells. It is of some interest that, when
fibronectin is added to transformed cells, the
microfilament bundles reappear.25,28 Con-
versely, when the microfilament bundles of
normal cells are disrupted by cytochalasin B,
fibronectin is released from the cell surface.29
These results suggest that fibronectin and
actin might be connected. Double-label
immunofluoreseence shows that, indeed, the
two arrays of filaments show strong corres-
pondences under a variety of conditions.30
It is conceivable, therefore, that fibronectin
is involved in adhesion and, in particular, in
the formation of adhesion plaques to which
actin microfilament bundles are attached, and
that this involvement is the basis for its
participation in a variety of cellular proper-
ties wihich alter on oncogenic transformation.
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THE ACTION OF GROWTH FACTORS
IN NORMAL AND TRANSFORMED
FIBROBLASTS IN CULTURE. P. S.
RUDLAND* & L. JIMENEZ DE ASUAt,
*Imperial Cancer Research Fund, London, and
tFriedrich Miescher-Institut, Basel.
Hormones are known to control many pro-
cesses of cell replication as well as those of
mnetabolic activity in the animal. However.
their effects in promoting proliferation of
fibroblastic cells in tissue culture are small
compared w%rith those obtainable with w!hole
serum. This suggests that the effects of whole
serum are produced by other agents and there
is evidence that low molecular proteins may
be important amongst these. Here we shall
confine ourselves to discussing growth factors
wNhich affect cultured fibroblastic cells, since
little detailed work has been done in other
systems. We shall define a growth factor for a
given cell as a, component which will stimulateABSTRACTS OF INVITED CONTRIBUTIONS
the multiplication of cells in a nutritionally
and otherwise complete medium for that cell,
at concentrations which are considered to be
near its physiological level.2 Growth factors
are probably best classified according to their
source, since relatively little is known about
their site of action in the animal. We shall
deal mainly with the pure polypeptides,
pituitary fibroblast growth factor, FGF,3
submaxillary epidermal growtlh factor, EGF,4
and the prostaglandin F2(x, PGF2o5 produced
by many cells. Most of the growth factors
have their growth-promoting activity modi-
fied by certain metabolic hormones such as
hydrocortisone and insulin, which alone have
little or no effect on cell proliferation.2
Before considering possible biochemical
mechanisms for the action of growth factors,
we should describe the observable effect of
growth factors on the cell cycle. When FGF
and hydrocortisone or 10% serum are added
to confluent, slowly proliferating BALB/c
3T3 cells (quiescent cultures) grown in
medium containing serum, the kinetics for
the increase in the fraction ofcells which have
entered S phase are nearly identical to the
kinetics for the increase in the number of
cells, except that the latter increase is de-
layed by 9-10 h.6 The simplest explanation of
this is that the duration of the remainder of
the cell cycle up to division is constant.6 In
another system (3T6 cells) when serum is
completely removed from the medium the
cells require additional components to pro-
gress through later stages ofthe cell cycle. but
these additional components probably do not
have a regulatory role.7 Growth factors such
as FGF,8 and PGF2a0 when added to
quiescent 3T3 cells cause an abrupt increase
in the rate of cellular entry into S phase after
a constant lag period. During the lag period
cells are entering S phase at a very low rate.
The initial and final kinetics seem to be first
order for PGF209 as they are for serum,10 and
can therefore be -described by a first-order
rate constant k; increasing concentrations of
PGF2a increase k. This observation is con-
sistent with the model of the cell cycle for
cells growing under constant conditions pro-
posed by Burns and Tannock"l and Smith
and Martin12 in which a random decay from
part of the G, phase to the remainder of the
cell cycle is governed by a first-order rate
constant y or ktrans. To explain the kinetics
obtained by addingPGF2oU or FGF at different
concentrations and different times in the
31
lag phase, two signals, 1 and 2 are
postulated. Signal 1 initiates the lag phase
and signal 2 determines the value of k. The
times during the lag phase when hormones
must be present to effect changes in the value
of k suggest that the pathway triggered by
signal 1 is organised in a linear sequence of
steps during this period, and that the change
in the putative rate-limiting step which is
responsible for first-order kinetics is situated
near the end of the lag phase.9"13"14 Similar
conclusions concerning the position of this
"rate-limiting step" have been obtained from
experiments with inhibitors of protein syn-
thesis.15
Turning to the detailed study of the inter-
action of growth factors with their target
cells, two basic mechanisms have been sug-
gested for EGF. (1) The growth factor binds
to specific receptors in the plasma mem-
brane16 and thereby triggers specific messen-
gers' (cyclic nucleotides, ions, nutrients)
which continue the stimulus inside the cell.
(2) The growth factor is internalized and goes
directly to intracellular sites17 concerned
with the growth stimulus. These possible
effects may not be mutually exclusive. Three
lines of evidence suggest that the first
mechanism cannot be the complete story.
(1) 3T3 cells partially starved for certain
nutrients cannot increase their proliferation
rates with FGF.18 (2) The magnitude ofearly
changes1"19 in cyclic nucleotide and ion con-
centrations and transport of nutrients trig-
gered by PGF2a or FGF do not necessarily
show correlations with the final value ofk.2,14
(3) EGF stimulates many ofthe early changes
in a 3T3 cell variant, but fails to increase the
value of k, whereas PGF2cx behaves normally,
suggesting an EGF-specific interactior with
the cell beyond plasma-membrane binding
(unpublished results). On the other hand
there is no evidence as yet to suggest that
internalization and accumulation of EGF by
the cell is involved in the delivery of the
mitogenic signal.20
Even more difficult to understand is the
constancy of the lag period, independent of
PGF or PGF2oX concentrations, before in-
creased values of k are observed. We have
suggested2 that the constancy of this period
is due to a requirement for interaction of the
pathways generated by signal 1 and signal 2
before an intracellular component becomes
..competent" to cause increased values ofk at
the end of the lag. The nature of this hypo-
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thetical component is unknown, but since
only the later events which result from
changes in the amount of proteins inside the
cell show consistent correlations with the
value of k to date,2 and since there is a strict
requirement for protein synthesis for changes
in k at the end of the lag phase,15 it is not
unreasonable to suppose either that this com-
ponent may be a protein which has to be
modified or a modification to the cell has to
take place before this component becomes
"competent" to cause an increase in k. One
obvious candidate is a cellular equivalent to
the small DNA tumour-virus nuclear T
antigen which can stimulate host-cell DNA
synthesiswheninjecteddirectlyinto quiescent
cells.21 Interestingly, the apparent relative
rate of accumulation of a nuclear non-
histone protein seen near the end of the lag
phase after addition of PGF2a to quiescent
cells is correlated with the final value of k.22
Experiments are in progress to isolatethis and
other proteins, and to test for their effect on k
by direct microinjection into quiescent cells
(L. J. de A., unpublished).
Chemical or viral transformation of fibro-
blasts in tissue culture produces cell variants
with different properties from the original
cells, including increased ability to form
tumours in animals (review ref. 23). One
different property is their response to growth
factors. Thus FGF can stimulate cell replica-
tion in untransformed 3T3 cells, but not in
polyoma or SV 40-transformed 3T3 cells6 or
in 3T3 cell transformation mutants at the
temperature at which the cells are trans-
formed.24 It has been suggested that a
possible mechanism for transformation in
vitro and forination ofa neoplastic cell in vivo
is due to an increased ability of cells to pro-
duce their own growth factors, so ensuring a
degree of cellular autonomy from external
control by growth factors present in
serum.25'26 In particular, the fact that
inurine sarcoma virus-transformed fibro-
blasts fail to bind EGF at the cell's surface
but produce EGF-like polypeptides which
compete for binding with EGF to cultured
cells, has suggested that the transforming
sarc gene product may be a growth factor
which binds to the plasma membrane, causing
the altered properties and failure ofthese cells
to bind EGF.27 This hypothesis fails to ex-
plain some of the other changes which
accompany transformation in fibroblastic
cells (e.g. cell-surface glycoprotein changes,
increased protease activity, reduced cell-
adhesive properties) which can be observed
independently of changes in proliferation
rates in temperature-sensitive mutant
BALB/c 3T3 cells.28'29 A more likely ex-
planation is that the sarc gene product has
more general effects on the plasma membrane,
one of which may be to alter its binding of
certain growth factors. However, it may not
be unreasonable to conceive that one of the
transforming viral gene products associated
with increasing host-cell proliferation rates,
the nuclear T antigen of the small DNA
tumour viruses, may be acting like the hypo-
thetical host-cell "component" for maintain-
ing increased cellular proliferation rates. In
this way the transformed cell may perpetuate
the stimulus for increased values ofk that the
growth factor produces in untransformed
cells.
REFERENCES
1 HOLLEY, R. W. (1975) Nature, 258, 487.
2 RTUDLAND, P. S. & JIMENEZ DE ASUA, L. (1978)
Biochem. Biophys. Acta Cancer Rev. (in press).
3 GoSPODAROWICz, D. (1975) J. Biol. Chem., 250,
2515.
4 COHEN, S., TAYLOR, J. M. & SAVAGE, C. R. (1974)
Rec. Prog. in Hormone Res., 30, 533.
5 JIMENEZ DE ASUA, L., CLINGAN, D. & RUDLAND,
P. S. Proc. Natl Acad. Sci. U.S.A., 72, 2274.
6 RUDLAND, P. S., SEIFERT, W. & GoSPODAROWICZ,
D. (1974) Proc. Natl Acad. Sci. U.S.A., 71, 2600.
7 RUDLAND, P. S., DURBIN, H., CLINGAN, D., &
JIMENEZ DE ASUA, L. (1977) Biochem. Biophys.
Res. Comm., 75, 556.
8 MIERZEJEWSKI, K.. & ROZENGURT, E. (1976)
Biochem. Biophys. Re.s. Comm., 73, 271.
9 JIMENEZ DE ASUA, L., O'FARRELL, M. K.,
BENNETT, D. C., CLINGAN, D. & RUDLAND, P. S.
(1977) Nature, 265, 151.
10 BROOKS, R. (1975) J. Cell Physiol., 86, 369.
11 BURNS, F. J. & TANNOCK, J. F. (1970) Cell Tissue
Kinetics, 3, 321.
12 SMITH, J. A. & MARTIN, L. (1973) Proc. Natl Acad.
Sci. U.S.A., 70, 1263.
13 JIMENEZ DE ASUA, L., O'FARRELL, M. K.,
CLINGAN, D. & RUDLAND, P. S. (1977) Proc. Natl
Acad. Sci. U.S.A.. 74. 3845.
14 JIMENEZ DE ASUA, L., RICHMOND, K. M.,
O'FARRELL, M. K., OTTO, A. M., KUBLER, A. M. &
RUDLAND, P. S. (1978) Cold Spr. Hb Symp.
Hormones and Cell Culture (in press).
15 BROOKS, R. (1977) Cell, 12, 311.
16 HOLLENBERG, M. D. & CUATRECASAS, P. (1975)
J. Biol. Chem., 250, 3845.
17 CARPENTER, G., & COHEN, S. (1977) J. Cell Biol.,
250, 3845.
18 KAMELY, D. & RUDLAND, P. S. (1976) Nature, 260,
51.
19 ROZENGURT, E. (1976) J. Cell Physiol., 89, 627.
20 Cold Spr. Hb Symp. Hormones and Cell Culture
(1978) (in press).
21 TJIAN, R., FEY, G. & GRAESSMANN, A. (1978)
Proc. Natl Acad. Sci. U.S.A., 75, 1279.ABSTRACTS OF INVITED CONTRIBUTIONS 467
22 OTFARRIELL, M. & DIXON, C. (manuscript in
preparation).
23 PASTAN, I. & WILLINGHAM, M. (1978) Nature, 274,
645.
24 RUDLAND, P. S., ECKHART, W., GOSPODAROWICZ,
D. & SEIFERT, W. E. (1974) Nature, 250, 337.
25 BURK, R. R. (1973) Proc. Natl Acad. Sci. U.S.A.,
70, 369.
26 TODARO, G. J., DELARCO, J. E. & COHEN, S. (1976)
Nature, 264, 26.
27 DELARCO, J. E. & TODARO, G. J. (1978) Proc.
Natl Acad. Sci. U.S.A., 75, 4001.
28 RUDLAND, P. S., PEARLSTEIN, E., KAMELY, D.,
NUTT, M. & ECKHART, W. (1975) Nature, 256, 43.
29 POUYSSEGUR, J. M. & PASTAN, I. (1976) Proc.
Natl Acad. Sci. U.S.A., 73, 544.
CELL COMMUNICATION IN NORMAL
AND MALIGNANT CELL POPULA-
TIONS. J. D. PITTS, Department of Bio-
chemistry, University of Glasgow.
Two mechanisms of cell-cell communica-
tion have evolved to allow the coordination
of cellular'functions in multicellular organ-
isms. One mechanism depends on extra-
cellular signal molecules (e.g. hormones,
synaptic transmitters); the other depends on
the formation of permeable intercellular
junctions. Both mechanisms appear to be
ubiquitous throughout the plant and animal
kingdoms.
The permeability of junctions formed
between animal cells is well established. Small
ions and molecules are freely exchanged
between the cytoplasms of all the cells in a
coupled population, but macromolecules re-
main within the cells where they were
synthesized (or their daughter cells which
arise through division).1.2 The exchange
appears to take place by simple diffusion
through specialized membrane structures
(gap junctions) which bypass the normal
permeability restrictions of the plasma mem-
brane.3A4
In excitable tissues, permeable junctions
can provide intercellular, low-resistance path-
ways for the propagation of electrical im-
pulses. In non-excitable tissues, where the
junctions are generally more numerous, they
allow the equilibration of metabolite pools
between cells. This can result in a tissue
"phenotype" which is characteristic of a par-
ticular mixture of cells and which is different
from the phenotypes ofthe'separated cells.
In model systems in tissue culture, it has
been shown that metabolic interactions
through permeable junctions can result in the
intercellular control of enzyme activities and
cell proliferation.5
Gapjunctions are found in most tissues, the
only notable exceptions being skeletal muscle
and some circulating cells. Tumour cells how-
ever, in all cases so far examined, have lost
either the ability to form permeable junctions
or the communication specificity of their
normal counterparts.6
These difference between normal and
tumour cells have led to the suggestion that
defects in junctional communication might
lead directly to the malignant state.7 The
evidence for and against this suggestion will
be presented and discussed.
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THE SURFACE PROPERTIES OF IN-
VASIVEANDMETASTATIC TUMOUR-
CELL POPULATIONS. G. POSTE, Depart-
ment of Experimental Pathology, Roswell Park
Memorial In8titute, Buffalo, NY 14263, U.S.A.
Evidence obtained in several laboratories
over the last few years has shown that
metastasis is not a random process in which
each cell in a malignant primary tumour is
capable of producing a metastatic lesion, but
is instead caused by specialized subpopula-
tions of cells within the primary tumour
which are endowed with the properties needed
to successfully complete all stages of the
metastatic process.1-3 Recognition that not
all the cells in a malignant primary tumour
possess the properties needed to metastasize,
has major implications for the choice and
design of experimental systems for the study
of metastasis. Studies on unselected. hetero-
geneous tumour-cell populations isolated
from the primary lesion may offer little in-
sight into the properties of metastatic cells,
since the proportion of non-metastatic cells
may be sufficiently high to prevent detectionI.C.R.F. AND B.A.C.R. JOINT SYMPOSIUM
of properties which are unique to the meta-
static subpopulation(s). Analysis ofthe malig-
nant phenotype thus requires isolation and
characterization ofsubpopulation(s) ofmalig-
nant cells endowed with the full complement
of properties needed for expression of meta-
static behaviour.
The isolation of tumour-cell populations
with invasive and metastatic properties has
required the development of new methods
whereby these cells can be reliably separated
from cells lacking these behavioural traits.
Recently, techniques have been devised
which permit quantitative measurement of
the ability oftumour cells to invade segments
of chick chorioallantoic membrane, murine
bladder wall and mammalian blood vessels
cultured in vitro, and which also enable the
invasive cell subpopulations to be reiso-
lated.4'5 Using these methods, a number of
cloned lines of tumour cells with enhanced
invasive and metastatic behaviour have been
isolated,5'6 and studies have begun to com-
pare how these cells may differ from non-
invasive and non-metastatic tumour cells
present in the original parent cell population.
Recent studies on the adhesion of cells to
collagen in vitro7 and to the surface of blood
vessels maintained in vitro in perfusion-
culture, have revealed majordifferences inthe
behaviour of normal and tumour cells which
may be relevant to the arrest of circulating
tumour cells in the vascular bed and their
subsequent extravasation to form micro-
metastases in the surrounding tissues. Normal
cells adhere equally well to collagens ofTypes
I, II, III or IV, but their adhesion is always
serum dependent.7 In contrast, metastatic
tumour cells display a significantly higher
affinity for adhesion to Type IV collagen and
adhesion is serum independent.7 Type IV
collagen is found in the basement membrane
of blood vessels, and these findings raise the
intriguing possibility that the greater affinity
of malignant cells for this substrate may aid
their metastatic behaviour in vivo by facili-
tating cell arrest and extravasation. Other
studies8 on the adhesion of normal and
tumour cells to blood vessels in vitro also
support this view. Normal and malignant
cells do not differ significantly in their ability
to adhere to intact endothelium, but meta-
static cells adhere more rapidly and in greater
numbers to blood vessels denuded of endo-
thelium. In the latter situation cell adhesion
thus occurs directly to the basement mem-
brane.8 Perhaps of more importance is that
the same differences in adhesion between
normal and malignant cells have also been
detected after minimal damage to the endo-
thelium, in which the endothelial cells remain
attached to the basement membrane but re-
tract to create large intercellular spaces
where the basement membrane is exposed.
Since structural alterations of this kind can
be induced in vivo merely by reduced blood
flow, this raises the possibility that local
alterations in blood flow created by the arrest
oftumour cells in capillaries might predispose
the vessel to adhesion of metastatic cells to
the basement membrane.
Clinical2'9 and experimental3"10-17 obser-
vations showing a predilection of certain
neoplasms for metastatic growth in specific
organs suggest that the pattern of metastasis
does not result from random arrest and
growth of tumour cells, but reflects features
of the circulating tumour cells, the host
vasculature and/or the organ environment
which cause selective growth in particular
`target" organs. Convincing evidence that
the properties of the tumour cells themselves
can in part determine the pattern of meta-
stasis has come from studies in which tumour-
cell variants that localize preferentially in
specific "target" organs have been isolated
from the same tumour-cell line. Variants of
the B16 mouse melanoma that localize
preferentially to the lung,3"19 the brain3"17 or
to the ovary have been isolated and found to
display differences in their surface proteins as
determined by lactoperoxidase-catalyzed
iodination.17 To study what role, if any, sur-
face alterations play in determining the arrest
and growth of these variants in particular
target organs, Garth Nicolson and I have
attempted to modify the arrest behaviour of
these cells by manipulating the composition
of their plasma membranes. This has been
achieved by fusing plasma-membrane vesicles
isolated from a B16 variant with high meta-
static activity that localizes in the lung with
a different B16 cell line which exhibits lowA
metastatic activity and does not metastasize
preferentially to the lung. Fusion of vesicles
with the recipient cells results in a significant
increase in the arrest of vesicle-modified cells
within the lung, followed by increased forma-
tion of lung metastases.19 These experiments
indicate that: (1) plasma-membrane com-
ponents present in the vesicles were able to
modify the arrest behaviour of the recipient
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cells; and (2) surface properties are ofimport-
ance in determining the arrest pattern of
circulating tumour cells. Further studies to
identify the plasma-membrane components
involved in determining specific patterns of
tumour-cell arrest are now in progress.
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ABSTRACTS OF OPEN PAPERS
CHARACTERIZATION AND PURIFI-
CATION OF PLASMA MEMBRANES
OF CULTURED HUMANPANCREATIC
ADENOCARCINOMA CELLS USING
SPECIFIC ANTISERA AND IMMUNO-
AFFINITY CHROMATOGRAPHY. S.
PAHLMAN, A. G. GRANT, J. HERMAN-TAYLOR
& I. LJUNGSTED-PAHLMAN, Dept. of Sur-
gery, St George's Hospital Medical School,
London.
Animmunofluorescent study ofthe plasma-
membrane antigens of an in vitro human
pancreatic-cancer line was carried out using
antisera to gastric and colonic cancer, normal
omentum, 32-microglobulin and gluteralde-
hyde-fixed whole cells. Persistent staining
after suitable adsorption of the whole-cell
antiserum suggested the presence of tumour-
specific determinants. The expression of /2-
microglobulin on the cell surface was used to
develop an immuno-affinity procedure for the
further purification of plasma-membrane
components by specific adsorption of the
membranes to immobilized anti-$2 antibody;
desorption was achieved by detergent solu-
bilization of retained membranes followed by
PAGE characterization.
SERUM P2-MICROGLOBULIN IN
CANCER. E. H. COOPER, R. A. D. BUNNING,
S. M. ILLINGWORTH, S. L. HAWORTH & S. A.
RASHID, Unitfor Cancer Research, University
of Leeds, Leeds.
/32-Microglobulin (f/2m) is an intrinsic part
of HL-A antigens and also occurs in the free
form on the surface of nucleated cells. In a
large percentage of untreated non-Hodgkin's
lymphoma (NHL) (68%) and Hodgkin's
disease patients (55%) serum f32m was raised
(>.30 mg/l). The probability of raised f32m
increased with more advanced disease, pos-
sibly indicating a relationship between /32m
and tumour load, as does the observed lower-
ing of /32m in some patients after chemo-
therapy. In remission, /2m levels tended to
be normal, though a group of HNL patients
was observed with persistantly high fl2m,
possibly due to residual disease. Most patients
with chronic lymphocytic leukaemia had
persistently raised f32m levels (76%) and
there was no correlation between /32m levels
and lymphocyte count. Elevated f32m was
also present in 82% ofpatients with Burkitt's
lymphoma. In bladder cancer patients with
normal renal function as determined by
serum creatinine levels, the frequency of
raised serum ,B2m increased with tumour
stage (15% TI, 57% T4) though a large num-
ber of patients had impaired renal function,
making serum fl2m measurement of little
value. Few elevated g2m levels were found
in prostatic cancer despite large tumour loads
(30% raised in a no treatment M+ group).
Whether this indicated low /32m production
by tumour cells or little host reaction to this
type of tumour is uncertain. /2m levels in
choriocarcinoma were also seldom elevated,
possibly a result of intensive chemotherapy
and immunosuppression or a deficit of HL-A.
The support of physicians and surgeons in
Yorkshire and elsewhere is acknowledged.
CELL-SURFACE GLYCOPROTEINS
AND GLYCOSAMINOGLYCANS (GA
Gs) OF HUMAN SKIN FIBROBLASTS.
J. T. GALLAGHER, N. GASIUNAS & S. L. SCHOR,
CRC Department ofMedical Oncology, Christie
Hospital & Holt Radium Institute, Manchester.
Cell-surface glycoproteins play important
roles in control of differentiation, cell inter-
actions and probably the proliferative and
metastatic abnormalities of tumour cells:
regulation of synthesis and expression of
specific glycoprotein ligands is clearly of
importance in these processes. We have
studied the effect of the cellular environment
on membrane glycoproteins and GAGs of
human skin fibroblasts by culturing cells on
plastic or collagen-gel substrates. Confluent
monolayers, incubated for 48 h with 3H-
glucosamine and Na235SO4, were extracted
with trypsin (0.5 mg/ml) when cultured on
plastic, and by trypsin followed by collage-
nase (2 mg/ml) for cells on collagen gels which
were not detached by trypsin. In cell-free
extracts, heparin sulphate (HS) was the main
sulphated GAG from cells on plastic with
dermatan sulphate (DS) the minor com-
ponent: on collagen gels, however, DS was
more abundant than HS. Collagen-gel cul-
tured cells were also enriched in cell-associ-
ated hyaluronic acid and a distinct acidic
glycopeptide. We conclude that the cellular
environment in vitro influences the synthesis
and disposition of cell-surface glycoproteins
and GAGs.
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PEANUT LECTIN RECEPTORS ON
BREAST EPITHELIUM AND THEIR
SIGNIFICANCE IN MAMMARY CAR-
CINOMA. R. A. NEWMAN, P. J. KLEIN &
P. RUDLAND, Imperial Cancer Research Fund,
London, & Pathology Dept., University of
Cologne, W. Germany.
The Thomsen-Friedenreich (TF) antigen-
specific lectin from peanuts was found to
stain apical surfaces of normal human breast
epithelium, when examined by fluorescence
microscopy or autoradiography, but not
myoepithelium or fibroblasts. Pre-treatment
of histological sections with neuraminidase,
however, increased staining over the total
epithelial cell surface, showing that both free
and sialic-acid-covered TF antigens are
present, and is in contrast to recent reports
that the TF antigen is a carcinoma-associated
antigen. Receptors for the anti-A-like lectin
from Helix pomatia gave a similar distribu-
tion. A number of benign and malignant
breast tumours were studied, and showved
distributions similar to normal tissue,
although the intensity of staining increased
with increasing tumour differentiation. Rat
mammary gland from young, virgin,
pregnant and lactating animals was also ex-
amined, as well as monolayer cultures of
epithelial cells, and the amount ofTF antigen
found to correlate with the secretory status of
the tissue. Peanut lectin can be used as a
marker for breast epithelium but cannot be
considered breast-carcinoma associated.
Conventional immunotherapy using the TF
antigen seems to offer poor expectations for
success, although the effect of infiltrating
tumours on cellular immunity remains to be
investigated.
ASPECTS OF APPLICATION OF
SECONDARY-ION MASS SPECTRO-
METRY ON BIOLOGICAL MATERIAL:
COMPARISON OF SPECTRA OB-
TAINED FROM GLIOMA AND GLIAL
CELL SURFACES. K. ZANKER,* D.
STAVROUt, W. GERHARDT, C. PLOGC & G.
BLfTMEL*. *Institute for Exp. Surgery, TUM,
tInstitute for Neuropathology, Veterinary
Medicinie, LMU, Munich, +Dornier System
GmbH.
Changes in cell surfaces are believed to be
involved in the regulation of cell growth. The
idea that the surfaces ofneoplastic cells differ
from those of their normal counterparts has
received support from various lines of re-
search. To substantiate this view by a
physical method, secondary-ion mass spec-
trometry (SIMS) was applied on N-methyl-N-
nitrosourea-induced pleomorphic glioma and
glial cell surfaces. SIMS allows researchers to
monitor small molecules, ofup to 10, probably
more, atoms, which can be derived from
various depths in the plasma membrane. All
spectra of the positive ions showed a pattern
of grouped peaks between 50 and 150 atomic
mass units (u). A comparison of the relative
distribution of the grouped peaks revealed
that the decrease of the impulse heights to-
wards higher u is steeper in the spectrum ob-
tained from glia than from glioma. In addi-
tion, glial and glioma cells showed a charac-
teristic positive ion peak at 148 u. The im-
pulse height ofthe 148u peak was significantly
lower within the glial cells, than the averaged
impulse heights ofthe above grouped spectral
lines. Evaluation ofthe 148 u in deeper layers
of the membrane exhibited a small, con-
tinuous decrease ofthe impulse height within
increasing membrane depths. The same ex-
periment with glioma cells revealed a
dramatic decrease of the 148 u in deeper
membrane layers. These results suggest that
(i) glioma cells express at the very topic ofthe
cell surface a higher quantity of molecule(s)
from which a 148 u can be fragmented than
do glial cells and (ii) there is a different dis-
tribution of the original molecules. Further
investigations should be undertaken to sort
out whether SIMS might become a powerful
tool for membrane-molecule fragmentation
and, thus, to contribute to understanding
neoplasia in terms of cell-surface transfor-
mation.
FELINE ONCORNAVIRUS-ASSOCI-
ATED CELL-MEMBRANE ANTIGEN
(FOCMA). J. C. NEIL, Department of
Veterinary Pathology, University of Glasgow
Veterinary School, Bearsden Road, Bearsden,
Glasgow.
Although infection of cats with feline
leukaemia virus (FeLV) is relatively com-
mon, leukaemia is a rare consequence. Re-
covery from FeLV infection is due to an
immune response to viral antigens in which
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virus-neutralizing antibodies are produced.
In addition, cats may make antibodies to a
virus-induced non-virion antigen (FOCMA)
which appear to protect them from the
leukaemogenic effects of the virus. Antibodies
to FOCMA were first recognised in cats with
regressing feline sarcoma virus-induced
tumours. Recently, FOCMA was defined as a
tumour-specific cell-surface antigen which is
induced in cats by FeLV infection and may
be coded for by the FeSV genome. It is also
found on leukaemic cells in cats with no
evidence of FeLV infection (virus-negative
leukaemias). We are attempting to isolate
FOCMA from tumour-cell lines using im-
munoprecipitation and SDS polyacrylamide-
gel electrophoresis. We thus hope to confirm
the immunological evidence for this antigen
and to assess its role in cell transformation and
in the immunity of cats to FeLV and its
leukaemogenic properties.
CELL-CYCLE-RELATED CHANGES IN
SURFACE MORPHOLOGY, VIRUS RE-
LEASE AND VIRAL-ANTIGEN EX-
PRESSION. S. TOTH, Department of Veterin-
ary Pathology, University of Glasgow.
Synchronized feline lymphoblastoid cells
(FL 74) chronically infected with feline
leukaemia virus (FeLV) have been examined,
during the different phases of the growth
cycle, by the combined means of cytoplasmic
and viable-cell indirect membrane-immuno-
fluorescence techniques (IFA), electron and
immunoelectron microscopy (EM, IEM) and
scanning electron microscopy (SEM).
Using IFA and EM techniques, it has been
found that virus production and viral protein
expression are cell-cycle dependent and occur
near mitosis.
In order to establish a more precise timing
of the above events, immunoferritin labelling
and SEM of synchronized cells were per-
formed.
Several distinct changes were found in sur-
face morphology, which correlated with the
subdivisions of the cell-cycle, and analysis of
the surface morphology, ultrastructure, the
number of budding C-type particles, the
distribution and intensity of ferritin-labelled
antigenic sites allowed the identification of
individual cells in the cell cycle.
CELL-SURFACE ANTIGEN AND RE-
CEPTOR EXPRESSION ON THYMIC
LYMPHOMAS OF THE GR MOUSE
STRAIN AND ON SOMATIC CELL
HYBRIDS WITH CHINESE HAMSTER
(E36) CELLS. J. HILGERS, J. HILKENS & A.
COLOMBATTI, Division of Genetics, The Nether-
lands Canccr Institute, Amsterdam.
Transplanted ascitic thymic lymphomas of
the GR mouse strain (GRSL) wvere compared
with thymocytes, for cell-surface antigens and
receptors. Three types of GRSL's could be
distinguished on the basis of Ly-antigen ex-
pression. The majority of leukaemias were
negative for Lyl.2 and Ly2.1, some were
positive for Lyl.2 only and so far one was
Ly2.1 positive. All 3 types of leukaemia ex-
press antigens not present on thymocytes,
such as the Mammary Tumour Virus-induced
MLr antigen (residing on the MTVgp52 en-
velope protein) and "extra" TL antigens.
These leukaemias express Thyl.2 antigen in
a low and variable way, due to "masking" by
carbohydrates. This is also the case for the
cholera-toxin receptor (presumably the GM1
ganglioside). Some antigens and receptors are
expressed better on GRSL cells than on
thymocytes, e.g. H-2K and H-2D antigens
and the Rauscher Leukaemia virus gp7O
receptor.
In order to study expression of these cell-
surface markers as a function of the "differ-
entiated" state, somatic cell hybrids segre-
gating mouse chromosomes were generated
between GRSL and Chinese hamster E36 lung
fibroblasts. Expression of H-2 antigens and
the 2 receptors, not present in E36, segre-
gated in the hybrids. Some, but not all,
fibroblast-like hybrids retaining chromosome
17 with the TLa locus, still expressed the
'extra" TL surface antigens, but so far all
clones retaining chromosome 9 with the gene
for Thyl.2 did not express this cell-surface
antigen. Expression of the MTV, both at the
cell surface and in the cytoplasm (radio-
immunoassays for MTVp27gag and MTV-
gp52env), was absent in all clones, even if the
full complement of MTV-DNA copies of the
GRSL parent were still present.
CIRCULATING TUMOUR-SPECIFIC
FACTORS: DIAGNOSIS OF PROGRES-
SIVE GROWTH OFA TRANSPLANTED
RAT HEPATOMA. J. G. BOWEN, D.
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HANNANT & R. W. BALDWIN, Cancer Research
Campaign Laboratories, The University,
Nottingham.
The inhibition of membrane-immuno-
fluorescence assay has been used to quantitate
tumour-specific antigens (TSA) in the circu-
lation of rats bearing the chemically induced
transplanted hepatoma D23. Rats were
inoculated either s.c. or i.m. with defined
numbers of viable hepatoma D23 cells. Free
circulating TSA was detected at about Day
7-10 in rats challenged with 5 x 105 D23 cells
s.c. or 4 x 104 cells i.m., andthe appearance of
free TSA coincided with the development of
palpable tumour. This initial peak of free
antigen was followed by a rise in the levels of
immune-complexed antigen during the later
stages of tumour growth after the induction
of a tumour-immune antibody response.
When the challenge dose of hepatoma D23
cells was close to the minimum inoculation
required for progressive tumour growth
(5 x 102 cells s.c.; 102 cells i.m.), there was a
delay in the appearance of palpable tumour
(about 20 days after inoculation), -11 days
beyond the time when free TSA was detected.
Inoculation of' y-irradiated (15,000 R) non-
viable hepatoma D23 cells failed to produce
evidence of free-circulating TSA when it was
detectable in rats inoculated with viable
tumour cells. These results indicate that the
presence of free hepatoma D23 antigen in the
serum of rats is diagnostic for tumour
growths, when the challenge inoculum is near
to the minimum inoculum. Furthermore, the
presence of antigen is a function of the
presence of viable tumour cells in the host.
A NEW HUMAN EPITHELIAL-MEM-
BRANE ANTIGEN (EMA). E. HEYDER-
MAN*, K. STEELEt & M. G. ORMERODt,
*Ludwig Institute for Cancer Research, Royal
M.arsden Hospital, and tlnstitute of Cancer
Research, Royal Cancer Hospital, Sutton,
Surrey.
We have demonstrated a new epithelial-
membrane antigen (EMA) using antisera
raised against defatted human cream and an
indirect immunoperoxidase technique on
routinely processed and fixed tissue sections
and on monolayers. The antigen is localized
on a wide variety of epithelia, including
normal and neoplastic mammary tissue,
adenocarcinomas from various sites, several
types of normal secretory epithelium and the
distal tubules and collecting ducts of the
kidney.
Although the distribution of the antigen is
widespread, it is highly selective, apparently
localized to membranes associated with a
secretory function and adenocarcinomas. We
lhave shown that EMA is different from
carcinoembryonic antigen (CEA), normal
cross-reacting antigen (NCA), fl-oncofoetal
antigen (BOFA), pregnancy-specific glyco-
protein (/31SP1) and the blood-group sub-
stances A, B, Lewis a and Lewis b, by com-
paring their distribution in various tumours
and some absorption studies. Like CEA in
poorly differentiated tumours, the antigen is
frequently cytoplasmic in distribution.
Since the antigen is carried by a variety of
adenocarcinomas its demonstration in minute
foci of malignant cells in the marrow and
lymph nodes is but one example of a possible
role in the diagnosis and differential diagnosis
ofmalignant disease.
LYMPHOCYTE-STIMULATION BY Ia+
AND Ia- ACUTE MYELOID LEUKAE-
MIAS AND CELL LINES. G. M. TAYLOR,
W. FERGUSSON &R. HARRIS, Dept. of Medical
Genetics, St Mary's Hospital, University of
Manchester.
Lymphocyte stimulation by Ia+ and Ia-
leukaemias and cell lines was studied.
Certain of the leukaemias and cell lines
stimulated allogenic lymphocytes in vitro;
others did not. Some of the non-stimulating
leukaemias were found to express Ia allo-
antigen by using poly-specific human anti-Ia
serum, and the p28,33 antigen detected by
rabbit antiserum. Variations were found in
different leukaemias in the proportion of Ia+
cells, and the strength ofantigen on individual
cells.
Lack of stimulation by Ia+ leukaemias
could not be attributed to poor viability, or
dependence upon 2-mereaptoethanol. The
relationship between lymphocyte-stimulating
and Ia antigens was assessed by in vitro
blocking of lymphocyte stimulation with
anti-Ia serum. Such parallel studies of
lymphocyte-stimulating and Ia antigens
should show how lymphocytes respond to cell
interaction (Ia) antigens on leukaemic-cells.
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SINGLE-CELL ANALYSIS OF CELLS
CARRYING LEUKAEMIA-ASSOCIAT-
ED ANTIGENS IN NORMAL AND RE-
GENERATING MARROW. G. JANOSSY,
M. F. GREAVES & F. J. BOLLUM, Dept.
Immunology, Royal Free Hospital and ICRF,
London.
The leukaemic blast cells in the common
form of acute lymphoblastic leukaemia and
in most cases of so-called "lymphoid" blastic
transformationi of Ph+ chronic myeloid
leukaemia show a characteristic phenotype.
These cells react with anti-ALL serum, carry
Ia-like antigens and contain, in the nucleus,
the enzyme terminal transferase. Antibodies
to these antigenic structures have been
developed and used in combination in order
to show that a few, small cells with lvmphoid
appearance can be found in regenerating
marrow. These marrow samples were taken
from patients who had had cytotoxic therapy
for malignancies other thani lymphoid leuk-
aemia or from non-leukaemic patients. These
cells could be the early haemopoietic stem
cells from which the malignancy of the same
phenotype arises. The clinical application of
this single-cell analysis will be discussed.
MEMBRANE SPECIALIZATION IN
CELL-SUBSTRATUM ATTACHMENT
SITES. T. D. ALLEN, M. J. BRITCH & C. J.
HARRISON, Department of Ultrastructure,
Paterson Laboratories, Christie Hospital &
Holt Radium Institute, Manchester.
The attachment of cells to substrata has
been characterized to date using the inter-
ference reflection microscope, with correlation
in the high-voltage electron microscope
(Heath & Dunn, 1978, J. Cell Sci., 29, 197).
These studies have indicated areas of attach-
ment between the cell underside and the
substratum that are limited to localized
"focal contacts", with some evidence for the
insertion of actin-filament bundles in these
regions (Abercrombie et al., 1971, Exp. Cell
Res., 67, 359). Studies in these laboratories
using an epithelial cell line from liver ob-
served during the process of spreading and
detachment, have characterized peripheral
regions of the cytoplasm which have been
interpreted as specialized cell-substratum
attachment sites. These areas have beenlin-
vestigated by whole-mount TEM and SEM of
the same cell, and also underside replicas
produced by freeze fracture. Ruthenium-red
staining ofthe whole-mount preparations has
also illustrated the production and involve-
ment of cell-coat material in these regions.
The regions of attachment are characterized
by a reticulate appearance of the peripheral
cytoplasm, in roughly circular regions of
5-10 ,um in diameter. These areas appear in
the lamellar regions of spreading epithelial
cells, or leading edges of fibroblasts, and
appear concomitant with a loss of membrane
ruffling. Initially these regions show no in-
sertion of microfilaments, but an association
may be developed subsequently. As well as
becoming the initial sites ofmembrane altera-
tion during settling and locomotion, these
areas are also the most resistant to the effects
of trypsin and EGTA and may consequently
correlate with the substratum-attached
material (SAM) which remains after cell
detachment.
FACTORS INFLUENCING CELL AT-
TACHMENT TO NATIVE COLLAGEN
FIBRES AND DENATURED COLLA-
GEN FILMS. S. L. SCHOR, J. COURT &
J. PRUDHOE, CRC Department of Medical
Oncology, Manchester University & Christie
Hospital & Holt Radium Instttute, Manchester.
The majority of previous reports dealing
with cell attachment to collagen have used
collagen films extracted with urea as a sub-
stratum; these studies have demonstrated
that cell attachment to such films is depen-
dentonahigh-mol.-wtglycoprotein (variously
known as LETS, fibronectin, CSP, CAP etc.)
found both in serum and on the surface of
normal fibroblasts. Inthe preseilt communica-
tion, we wish to report that only cell attach-
ment to denatured collagen films is dependent
on this glycoprotein, and that cell attachment
to native collagen fibres is mediated by a
different (serum-independent) mechanism.
This conclusion is supported by observa-
tions comparing the kinetics and extent of
cell attachment: (a) to various types of
collagenous substrata; (b) following treat-
ment of the cells with either EGTA oinly
or EGTA+trypsin (to remove the cell surface
LETS) and (c) in the presence and absence of
foetal calf serum.
474ABSTRACTS OF OPEN PAPERS
QUANTITATIVE MORPHOLOGICAL
CHANGES AT THE EPITHELIAL-
CONNECTIVE TISSUE JUNCTION
DURING ORAL CARCINOGENESIS.
F. H. WHITE & K. GOHARI, Department of
Oral Pathology, University of Sheffield.
The basal-lamina complex together with
the hemidesmosomes are thought to be re-
sponsible for epithelial-connective-tissue ad-
herence. Ulstrastructual studies have demon-
strated marked alterations in this region in
both human neoplastic development and in
chemical carcinogenesis. This study was de-
signed to investigate some ofthese alterations
using quantitative methods. Biopsies were
obtained from 7,12 dimethylbenz(cc)anthra-
cene (DMBA)-treated pouches which demon-
strated defined histological features corres-
ponding to hyperplasia (H), dysplasia (D) or
carcinoma (C). Untreated pouch epithelium
served as control (N). Stereological inter-
section counting procedures were used to
estimate relative surface parameters for
hemidesmosome and basal plasma membrane
(HD/BM) hemidesmosome and lamina densa
(HD/LD) lamina densa and basal membrane
(LD/BM) and mean hemidesmosomal dia-
meter ( HD). Results were as follows:
HD/BM: N=0-40; H=0-34; D=0-28;
C=0-13.
HD/LD: N=0-40; H-0-39; D-0-37;
C=0-30.
LD/BM: N=0-98; H=0-88; D=0-76;
C=042.
!HD: N=0-23; H=0-23; D=0-22;
C=0-20.
The results indicate a progressive decrease
of both hemidesmosomes and basal lamina
during carinogenesis. Quantitative evaluation
of these structures in human neoplastic de-
velopment may prove to be useful diagnostic
and prognostic indicators.
THE COMMUNICATION PATTERN
OF CULTURED HUMAN BREAST
CELLS. I. FENTIMAN & J. TAYLOR-
PAPADIMITRIOU, ICRF, London.
The pattern of direct communication of
cells derived from the human breast has been
examined in culture, using the 3H-nucleotide
transfer method. Normal human mammary
epithelium from a variety of sources has been
found to demonstrate selectivity in com-
munication. Thus although HumE com-
municate with homologous cells, no transfer
of nucleotide occurs from HumE donors to
fibroblast recipients, including those derived
from thehuman breast (Fentiman etal. (1976),
Nature, 264 760).
This work was extended to human breast-
cancer cells, either primary cultures obtained
directly from tumours, or established lines
derived from either primary carcinomas or
pleural-effusion metastases. Primary tumours
yielded 2 epithelial populations, one of which
was indistinguishable morphologically from
normal mammary epithelium. The other cells,
designated HumEl, arose from about one
third of primary and metastatic carcinoma,
and may represent the actual malignant cells.
HumEl as donors showed 2 patterns of
communication, being either non-communi-
cators, or non-selective communicators, i.e.
capable of transferring nucleotide to any cell
type capable of communication. A similar
pattern was shown by established lines
(Fentiman & Taylor-Papadimitriou (1977),
Nature, 269, 156). This loss ofselectivity may
confer survival benefit on metastizing cancer
cells. Further, this change in pattern of com-
munication may serve as a parameter for
distinguishing normal from malignant human
breast epithelium in culture.
NEURAMINIDASE-MEDIATED MOD-
IFICATION OF METASTATIC DI-
SEASE BY BLOOD LYMPHOCYTES
CULTURED WITH PRETREATED
TUMOUR CELLS. E. WATKINS, JR., L. L.
ANDERSON, 0. L. BARALT, R. B. MAHONEY,
S. C. HOLLIS & G. J. HEATLEY, Sias Research
Laboratory, Lahey Clinic Foundation, Boston,
Mass., USA.
Diethylstilboesterol - induced oestrogen -
sensitive mammary carcinoma MT/W 449
(syngeneicinWF rats) shows 100% metastasis
to lung and lymph nodes after amputation of
hind limbs bearing trocar tumours .12 mg
in male WF/Sch rats (71/71 animals, MST
after implantation 114 days, range 80-197).
I.p. injection 6 days after amputation of 1-40
x 106 Methocel-Hypaque peripheral-blood
lymphocytes (PBL) cultured 6 days with
MT/W449 tumour cells pretreated with V.
cholerae neuraminidase (VCN) significantly
prolonged actuarial cohort survival (MST 129
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days, 11/62 animals (17-7%) disease-free
beyond longest control survival, range 220-
534 days, P=0.0006). Optimal prolongation
of survival was seen after injections of
20-30 x 106 PBL cells. No such protective
effects were seen after similar injection
of PBL cultured alone. PBL cultured with
sham-pretreated MT/W 449 cells, or sham-
pretreated or VCN-pretreated MT/W 449
cells injected immediately after amputation
or after 6 days culture.
The immunogenic effect of VCN-pretreat-
ment of tumour cells may be related to
tumour-cell-bound enzymatically active
VCN co-ligating with PBL cell-surface glyco-
protein, as indicated by increased tumour-
cell-PBL rosette formation and biphasic
release ofadditional free sialic acid when pre-
treated washed tumour cells are mixed wvith
PBL. Non-specific inhibition of immunogenic
effect by acute-phase serum sialoglycoprotein
may be related to competition of such pro-
teins and PBL surface glycoproteins for
tumour-bound VCN enzymatic binding sites.
(USPHS-NCI Grant CA 18938)
STUDIES ON METASTATIC SPREAD
OF PRIMARY TUMOURS. D. TARIN &
J. E. PRICE, Department of Histopathology,
Royal Postgraduate Medical School, Hanmer-
smith Hospital, London.
A model has been developed for studying
the capability of cells from primary mam-
mary tumours to establish colonies in distant
organs. The aim was to avoid the use of re-
peatedly transplanted tumours or serially
propagated tumour cell lines. The model in-
volves the intravascular inoculation of dis-
aggregated tumour cells into autochthonous
and syngeneic recipients. The results show
that the colonization potential of cells from a
given tumour is consistent between the
animals of an inoculated batch. Also, the
findings are similar in the autochthonous host
and the syngeneic recipients. Tumours vary
in their metastatic colonization potential and
can be classified into high and low groups.
These findings indicate that:
(i) A significant proportion of mammary
tumours (40%) are capable of establishing
colonies in distant organs even though the
incidence of metastatic spread of these
tumours in the undisturbed animal is almost
zero.
(ii) The colonisation potential of the
tumours is an intrinsic property ofthe tumour
cells rather than of the host.
The model will now be used to study cellu-
lar properties which favour colonization of
distant organs.
A COMPARISON OF THE SURFACES
OF TUMOUR CELLS ISOLATED FROM
A METASTASIZING AND A NON-
METASTASIZING LYMPHOSAR-
COMA. G. A. TURNER, A. L. LATNER, D.
GuY & G. V. SHERBET, Department of Clinical
Biochemistry, Royal Victoria Infirmary, New-
castle upon Tyne.
Collagenase treatment isolates single cells
from solid tumours without substantial dis-
ruption of the cell surface (Guy et al., 1977,
Br. J. Cancer, 36, 166). Using this preparative
procedure, surface properties of cells from a
metastasizing (ML) and a non-metastasizing
(NML) lymphosarcoma (Carter, 1966, Am. J.
Path., 49, 637) were compared in respect of
adhesion to polystyrene-coupled lectins
(Edelman et al., 1971, Proc. 7Nlatl Acad. Sci.,
68, 2153); cytopherometry (Latner & Turner,
1974, J. CellSci., 14, 203); isoelectric focusing
(Sherbet & Lakshmi, 1973, Biochim. Biophys.
Acta,298, 50); and radioiodination (Guy et al.,
1977). Primary ML and NML cells gave
identical surface radiolabelling and cell-ad-
hesion patterns, isoelectric points of 4-65 and
4.49 pH units respectively, and electro-
phoretic mobilities of 2-09 and 1 46 /tm
sec-1 V-1 cm respectively. No differences
could be detected in surfaces of primary and
secondary cells from the ML tumour. These
data suggest that the acquisition of meta-
static capability is accompanied by a general
rather than a specific change in the cell-
surface profile.
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REPLICAS OF THE CELL SURFACE
AND UNDERSIDE MEMBRANE. M. J.
BRITCH & T. D. ALLEN, Department of Ultra-
structure, Paterson Laboratories, Christie Hos-
pital and Holt Radium Institute, Manchester.
Recently several methods for in situ freeze
fracturing of cultured cell monolayers have
been reported. The method of Pauli et al.
(1977, J. Cell Biol., 72, 763) has been modified
to produce replicas of the cell surface and
underside.
Cells were cultured to confluency on plastic
coverslips. Two coverslips drained of excess
medium, were sandwiched in a drop of poly-
vinyl alcohol. The cellular sandwich was then
quenched in melting N2 at 63K. The two
coverslips were fractured apart under liquid
N2 and transferred to a modified cold stage in
the NGN FE600 freeze-etch mnachine. The
cells were etched for 5 min in a working
chamber evacuated to less than 1 33x 10-4
N/mi2.
Replicas of the cell surface and the cell
underside were collected. Underside replicas
produced by shearing of the frozen cells from
the substrate demonstrate the relationslhip of
microfilament bundles to the underside mem-
braile. Areas of membrane perturbation,
widely distributed in the underside mem-
brane, have been interpreted as sites of mem-
brane-substrate interaction, disturbed by
shearing of the cells from the substrate. They
correspond closely to the adhesion sites ob-
served in w%hole-cell TEM.
Replicas of the cell surface of unfixed
frozen cells were also examined. The surface
nmorphology ofrounded-up mitotic fibroblasts
was basically similar to that of chemically
fixed, coated cells observed in the SEM. High-
resolution TEM has revealed considerable
surface detail. The surface is highly folded and
is frequently thrown into ridges. Microvilli.
clearly seen as modified surface folds, are
often associated with these ridges.
THE METHOD OF CELL ROUNDING
IN THE PRESENCE OF TRYPSIN IS
CELL-SHAPE DEPENDENT. C. J. HAR-
RISON & T. D. ALLEN, Department of Ultra-
structure, Paterson Laboratories, Christie Hos-
pital and Holt Radium Institute, Mlanchester.
The exposure of cells to trypsin revealed
the series of events leading to the assumption
ofa spherical morphology prior to cell detach-
ment from the substratum. It was seen that
the method of cell rounding was cell-shape
dependent.
Fibroblasts possess points of adhesion at
the tips of their polar regions. Continued
trypsin-induced cytoplasmic contraction
applied stress to the adhesion points until
attachment was released at each pole in turn.
This produced recoil ofthe polar regions under
elastic tension to produce spherical cells w%Nith
a blebbed surface morphology.
Cells of epithelial outline assumed a
spherical shape with a microvillous cell sur-
face bv slow retraction of the cvtoplasm
around the entire cell periphery. An epithelial
outline wvas maintained throughout the
rounding-up process. The alteration of cell
shape as fibroblasts progressed through the
cell cycle by transformation or induced bv
various experimental metlhods shoNwed the
same results.
VISUAL MARKERS FOR CELL-
SURFACE RECEPTORS IN THE SEM.
S. L. GOODMAN, G. M. HODGES & D. C.
LIVINGSTONE, Imperial Cancer ResearchFund,
London.
The visual detection and localization of
specific molecules on1 the cell surface by SEM
is possible using probes such as colloidal gold,
methacrylate latex spheres and defined silica
spheres. This approach is being applied to
studies designed to explore and correlate the
expression and topographical distribution of
cell-surface components with cell-surface
features in normal and neop)lastic tissues.
Work is currently in progress to evaluate the
characteristics, preparation and further
applicability ofthese probes and their ligand-
marker conjugates.
CELL-SURFACE MORPHOLOGY AS-
SOCIATED WITH CYTODIFFERENT-
IATION AND NEOPLASTIC TRANS-
FORMATION OF UROTHELIAL TIS-
SUES. G. M. HODGES, Imperial Cancer
Research Fund, London.
There is clear evidence that urothelia
maturation is associated with a series ofw%ell-
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defined changes in the architectural organiza-
tion of the urothelial cell surface. This is
revealed as progressive development and
fusion of small globular microvilli into the
characteristic convoluted angular membrane
infolds of the fully differentiated superficial
urothelial cell. By contrast, this surface-
pattern sequence iF modified in chemical-
carcinogen-treated urothelium or in human
bladder tumours, frequently in association
with the development of microvilli of a pleo-
morphic nature. Current evidence suggests
that such changes in surface properties should
be of value as an indicator of neoplastic
transformation.
PLASMA MEMBRANES AND CELL
CYCLE IN MOUSE PAROTID GLANDS.
R. 0. LOPEZ-SOLIS & J. P. DURHAM, Depart-
ment of Clinical Oncology, University of
Glasgow.
Isoproterenol (IPR), a synthetic catechol-
amine, induces cell proliferation in acinar
cells of mouse parotid glands when injected
i.p. The role of the plasma membrane in the
induction of DNA synthesis is being studied.
Plasma membranes from this tissue were
isolated by differential and discontinuous
sucrose-gradient centrifugation at different
stages of the cell cycle, and the activity of
different enzymes known to be "markers" for
these plasma membranes were studied in
order to have an additional element of
structural and functional analysis of this
compartment of the cell cycle. The results
show that between 0 and 28 h (injection of
IPR and onset ofDNA synthesis respectively)
the specific activities of these plasma-
membrane markers change continuously,
which could reflect an active role of the cell
surface during the cell cycle. Moreover, the
description of changes in specific molecules
with better known physiological functions
could help to understand the participation of
the cell surface between the stimulation and
onset ofDNA synthesis.
PROTEINS AND GLYCOPROTEINS
ON HUMAN MELANOMA CELLS. G. P.
ROBERTS & D. L. JONES, University Depart-
ment of Surgery, Welsh National School of
Medicine, Cardiff.
L'Characterization of the cell-surface com-
ponents of tumour cells is important for an
understanding ofthe role these materials may
have in malignancy. We have used iodination
with 125J in the presence oflactoperoxidase to
label the cell-surface proteins and glyco-
proteins ofmelanoma cells. The labelled com-
ponents were separated by SDS electro-
phoresis on 5-22.5% polyacrylamide gradient
gels and detected by autoradiography. Frac-
tionation of extracts of the labelled cells by
affinity chromatography on immobilized
lectins indicated that both proteins and
glycoproteins were labelled. Identification of
some of the labelled bands was achieved by
addition of immune sera to extracts of the
iodinated cells followed by examination of
the immune complexes retained on Staphylo-
coccus aureus. In this way proteins originating
from foetal calf serum used in the culture
medium and glycoproteins cross-reacting
immunologically with those of erythrocytes,
lymphocytes and fibroblasts were detected on
the melanoma cell surface.
ISOLATION AND CHARACTERIZA-
TION OF A MEMBRANE ANTIGEN
FROM ACUTE LYMPHOBLASTIC
LEUKAEMIA. R. SUTIIERLAND, J. SMART &
M. F. GREAVES, Imperial Cancer Research
Fund, London.
We have previously documented the
presence of a cell-surface antigen found in
acute lymphoblastic leukaemia, chronic
myeloid leukaemia in blast crisis and some
lymphomas (Greaves, et al. (1975), Clin.
Immunol. Immunopath., 4, 67; Roberts et al.
(1978) Leukaemia Rcs., 2, 105). This antigen
is also expressed on established cell line's
derived from these leukaemnias (Minowada
et al. (1978) Natl Cantcer Inst., 60, 1269) which
we have used as a convenient cell source from
which to isolate the antigen (Sutherland et al.
(1978) Leukaemia Res., 2, 115). Cells were
labelled with either 1251 by the lactoper-
oxidase technique or with 35S methionine or
3H-leucine for metabolic labelling. Total cell
extracts, purified cell membranes or culture
supernatant were used as a source ofantigen,
membranes being solubilized in NP-40 de-
tergent. Sepharose-lentil and Sepharose-ricin
lectin columns were used to purify glyco-
proteins and the ALL antigen was affinity
purified from these by precipitation with anti-
ALL antibodies on S. aureus. Antigen eluted
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from the bacteria was run in polyacrylamide-
gel electrophoresis and its position and
apparent mol. wt determined after autoradio-
graphy or fluorography. The results show that
the ALL antigenic determinant is released
from cells on a single glycosylated polypep-
tide with an apparent mol. wt of 100,000.
Membrane-associated ALL antigen may be
disulphide linked to a smaller component,
giving an apparent mol. wt on non-reducing
conditions of 130,000. The molecule is homo-
geneous by isoelectric focusing (5 8).
BIOPHYSICAL CHANGES OF CELL
MEMBRANE DURING THE GROWTH
OF AN ASCITIC TUMOUR. P. BISCHOFF,
F. ROBERT & M. DONNER, INSERM, Unit
of Experimental Cancerology and Radio-
biology, Plateau de Brabois, 54500 Vandoeuvre-
les-Nancy, France.
There is a considerable interest in studying
the electrical charge of cell surfaces, since it
is accepted that the interactions of cancer
cells with host immunocompetent cells are in
part determined by the physicochemical
nature of the cell periphery (Sanford &
Codington (1971) Tissue Antigens, 1, 153). An
ascitic tumour (SEWA) induced by polyoma
virus in A.SW mice was analysed in vivo as
well as in vitro with regard to the electro-
phoretic mobility (EPM) which may be con-
sidered as a reliable criterion of surface
charge. After the i.p. inoculation of 105 cells,
the EPM decreased up to 14th day (1-30 ,tm/
sec/Vcm). Then the mobility gradually in-
creased with the age of the tumour. The
EPM was 1-58 ,um/sec/Vcm for 28-day-old
tumours. Chemical modification of cell sur-
face with maleic anhydride and neuramini-
dase showed important variations of ionized
chemical groups in 14- and 28-day-old
tumours. Amino groups showed a drastic
decrease during the late phase of tumour
growth. In contrast, the number of o-car-
boxyl groups of N-acetyl neuraminic acid
markedly increased. On the other hand,
incubation with antisera of mice immunized
against SEWA are without effect on electro-
phoretic mobilities. When SEWA was main-
tained in vitro, the EPM reached a peak
24 h after renewal of the medium. This
increase was not seen when cells were
treated with cytosine arabinoside. Though
EPM variation in this case may be
interpreted on the basis of cell-proliferation
kinetics, the interpretation of in vivo results
is more complex. These results led us to
suggest that changes observed in vivo might
be the consequence of different independent
parameters. Besides intrinsic factors such as
cell kinetics, extrinsic factors are able to
modify pericellular environment. We have
considered the possibility of cell coating by
immunoglobulins present in ascitic fluid.
COMPUTER ANALYSIS OF IMMUNO-
FLUORESCENCE DATA OBTAINED
WITH FLOWCYTOMETRIC SYSTEMS.
J. V. WATSON, T. PEARSON & A. ZIEGLER,
M.R.C. Laboratories of Clinical Oncology and
Molecular Biology, The Medical School, Cam-
bridge.
A computer model has been developed to
analyse data obtained from cell-surface-
marker labelling using flow systems. Peri-
pheral lymphnode cells of C57BL/10 and
BALB/c mice were treated with serial dilu-
tions of a fluorescinated monoclonal anti-
mouse "IgD" reagentandanalysed in 2 differ-
ent flow systems, a model 4800A Cytofluoro-
graf (CFG) and a Fluorescence Activated Cell
Sorter (FACS). Comparisons of the predicted
proportions of labelled cells from the com-
puter analysis with those from conventional
integration above and below an arbitrary
level set "by eye" in each instrument, permit
the following conclusions. (1) Due to the high
coefficient of variation and low laser power of
this model of the CFG, an accurate quantita-
tion of data can only be obtained by com-
puter analysis. (2) Both the conventional
integration above and below an arbitrary
response level set "by eye" and the computer
analysis gave similar results with the FACS,
but the data indicate that the discriminating
level should be checked by computer if the
conventional method is chosen. (3) Whichever
instrument, or method of data evaluation is
chosen, it is essential to carry out experiments
with serial dilutions of the fluorescent anti-
serum to determine the optimum experi-
mental conditions. (4) It is necessary to
determine the fraction of non-specifically
labelled cells in the sample,"even with mono-
clonal reagents.
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CELL SURFACE CHANGES IN CAN-
INE MAMMARY CARCINOMA. R. W.
ELSE, Department of Veterinary Pathology,
University ofEdinburgh, D. HANNANT, Cancer
Research Campaign Laboratories, Unhlersity
of Nottingham.
Existing knowledge of spontaneous canine
mammary carcinomas indicates that although
40-50% of tumours can be surgically ablated.
other histologically similar neoplasms are
more aggressive, with a greater propensity to
metastasis. There is also a proportion (900) of
benign tumours which undergo malignant
transformation. The reasons for the apparent
differences and changes in relative immuno-
genicity ofthese tumours is unknown. Recent
studies (Hannant & Else (1978) Vet. Rec., 103,
in press) have shown that dogs with solid-
type mammary carcinomas have circulating
immune complexes with a tumour-associated
antigen component. In addition, TEM and
SEM of primary tumours, metastases, cul-
tured cells and tumour-cell suspensions of
solid-type carcinomas demonstrated cyto-
plasmic and surface-membrane changes. The
latter are characterized chieflv by extensive
microvillous proliferation and absence of
glycocalyx compared with normal epithelial
cells. These surface changes may be of signifi-
cance in relation to the metastatic potential
of the tumours. They may also be a morpho-
logical expression of different antigenicity
and therefore reflect, relative tumour immuno-
genicity.
ANTIGENS OF 3-METHYLCHOLAN-
THRENE-INDUCED RAT SARCOMAS:
HETEROGENEITY WITHIN PRIMARY
TUMOURS AND DIFFERENCES BE-
TWEEN PRIMARIES AND METASTA-
SES. M. V. PIMM, Cancer Research Campaign
Laboratories, University of Nottingham.
It was previously found that tumour re-
currences at the site of excision of primary
MCA-induced rat sarcomas were antigeiiically
distinct from the resected primary tumour
(Pimm & Baldwim (1977) Int. J. Cance;-, 20,
37). This may reflect development ofdormant
neoplastic cells after surgical removal of an
antigenically homogeneous primary tumour,
or alternatively true antigenic heterogeneity
within the primary growth, as suggested by
the earlier work of Prehn (1970, J. Natl
C,ancer Inst., 45, 1039).
To examine these possibilities further, in
the present study the antigenicity of in vivo
lines established from opposite poles of pri-
mary sarcomas have been compared, and
with one primary tumour-bearing animal the
antigenicity of lines established from peri-
toneal, renal and pulmonary metastases have
also been examined. Sublines from 4 primary
tumours cross-reacted, so that immunization
against one line conferred protection against
the other. With a 5th tumour, neither subline
was antigenic, although they had similar
growth characteristics. In contrast, sublines
from 3 furthler sarcomas were antigenically
distinct, so that immunization against the
subline from one pole failed to protect against
the other. Furthermore, with one primary
sarcoma, while the line from a peritoneal
metastasis tross-reacted -vith lines from the
primary tumour, neither of these cross-
reacted with lines from pulmonary and renal
metastases, although these latter were cross-
reactive with each other.
These studies demonstrate that antigenic
heterogeneity can exist within established
priinary tumours, and that metastases may
be antigenicallv distinct from the primary
tumouir.
SURFACE ANTIGENS ON NORMAL
AND TRANSFORMED LYMPHOID
CELLS. C. M. STEEL, V. VAN HEYNINGEN,
D. L. DEANE & B. B. COHEN. MRC Clinical
and Population Cytogenetics UTnit, Edinburgh,
& C. H. W. HORNE & A. W. THOMSON,
Department of Pathology, Aberdeen University
Mledical School.
Most long-term established B lymphoid cell
lines are potent activators of allogeneic or
autochthonous T lymphocytes in mixed
lymphocyte culture (MLC). The property is
not dependent on the presence of EB vi-rus in
the transformed lines. Untransformed B cells
also stimulate in MLC. tlhough muchi more
wA,eakly.
One "variant" EBV-cari-ving B cell line
(EB1) is markedly deficient in MLC stimu-
lating capacity although it expresses surface
HLA (including DR) antigens. A rabbit anti-
serum raised against human B lympho-
blastoid cell (DAUDI) membranes and then
serially absorbed with T cell lines and EB,
cells, displays only wveak residual complement-
dependent cvtotoxicity (i.e. it has little con-
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ventional anti-]DR activity). Nevertheless,
IgG from this antiserum binds to the surface
of those B-cell lines capable of stimulating in
MLC, as can be demonstrated in immnuno-
fluoresence and EM immnunio-ferritin labelling
tests. The antibody can also be shown to in-
hibit MLC reactions, but does not impair
lymphocyte responses to soluble mitogens.
The antigen(s) which it detects appear to be
expressed on untransformed B lymphocytes
as wAell as transformed B lymphoblastoid cells,
though there may be important quantitative
difference .
Competitive blocking tests indicate a very
close association between the antigens de-
tected by the above antiserum and preg-
nancy-associated alpha2 glycoprotein (0Z2-
PAG) which has been implicated in the
regulation of lymphocyte-mediated immune
reactionis.
THE ASSOCIATION OF HOST IM-
MUNOGLOBULINS WITH SOLID
TUMOURS IN VIVO. K. JAMES, J.
MERRIMAN & Y. BESSOS, Department of
Surgery, University of Edinburgh Medical
School.
In order to ascertain w%Ahether circulating
antitumour antibodies are capable of inter-
acting with tumour cell-surface antigens in
vivo we have developed techniques to detect
Ig on freshly excised tumours. The tech-
niques einployed include a direct and indirect
radioimmune antiglobulin technique which
permits a semi-quantitative assessment of
tumour-associated mouse Ig, and a com-
petitive radioimmunoassay technique which
enables the precise quantitation of mouse Ig
classes and sub-classes in NP 40 extracts of
freshly excised tumours. Using these pro-
cedures we have found that the amount of Ig
associated with tumours in vivo is dependent
upon the immunogenicity ofthe tumours, the
source of the initial tumour inoculum (i.e.
whether freshly excised tumour of cultured
tumour cells) and can be increased by ad-
ministration of the adjuvant C. parvum.
Furthermore, the tumour-associated Ig is
heterogeneous in nature. Additional studies
indicate that this binding cannot be attri-
buted to a host response to endogenous
C-type virus. Preliminary studies have also
been performned to determine the cellular
32
basis of this response and the specificity of
the tumour-associated Ig.
CELL-MEDIATED IMMUNE RES-
PONSE RELATED TO CARCINOMA
OF THE CERVIX UTERI. E. L. MURRAY,
F. SHARP & C. T. C. BOWIE, Departments of
Pathology and Gynaecology, University of
Glasgow.
We have used the leucocyte-migration-
inhibition test as an index of cell-mediated
immune response to material derived from
carcinoma of the cervix and normal cervical
epithelium, in groups of patients and control
donors. These control donors comprised pre-
operative patients with benign gynaecological
lesions and having a normal cervical smear.
Higher reactivity to tumour-derived antigen
was found in patients with invasive car-
cinoma of the cervix than in control donors.
Reactivity with the same tumour extract in
patients with preinvasive lesions of the
cervix (carcinoma in situ and dysplasia) was
less than that found in the benign control
wtomen. The diagnosis was established in each
of the former by colposcopy and selective
punch biopsy after collection of the blood for
examination. In 4 cases with microinvasive
lesions of the cervix, no reactivity was found.
CIRCULATING IMMUNE COMPLEX-
ES ASSOCIATED WITH GYNAECO-
LOGICAL CANCER. P. J. McLAUGHLIN,*
M. R. PRICE*, R. W. BALDWIN*, ID. P.
VASSEYt, & E. M. SYMONDSt, *Cancer Re-
search Campaign Laboratories, Nottingham,
and tDepartment of Obstetrics and Gynae-
cology, City Hospital, Nottingham.
We have tried to detect raised levels of
circulating immune complexes in patients
Awith ovarian cancer, using a variety of assays
which are based upon interaction of com-
plexes w!ith components of the complement
system. These assays include the direct Clq-
immune complex precipitation test as de-
scribed by Hdffken et al.. 1977 (Br. Med. J.,
ii, 218), the Clq-binding inhibition test
(Fletcher & Lin (1977) J. Immunol. Meth., 15,
39) with which the capacity of native and
decomplemented serum to inhibit the binding
of1251-Clq to IgG aggregates is measured, and
the Raji cell-binding test (Theofilopoulos et al.
(1976) J. Clin. Invest. 57, 169). With 8
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ovarian cancer (Stage II-IV) patients, pre-
and post-operative serum samples exhibited
equivalent reactivity in these assays, and the
immune-complex levels did not differ sig-
nificantly from those of age-matched, non-
malignant surgical control patients (8) or
normal young female controls (25). In pre-
liminary tests, elevated Clq-binding activity
was however detected in patients (10/16)
with other gynaecological tumours including
carcinoma of the cervix and uterus as well as
cervical dysplasia. These studies highlight the
need for defining the malignant diseases in
which measurement of immune complexes
may prove of value in immunodiagnosis and
prognosis.
DETECTION OF FREE LIGHT-CHAIN
IMMUNOGLOBULINS WITH CLINI-
CAL POTENTIAL AS TUMOUR MAR-
KERS. D. F. TUCKER, J. KEEN & R. H. J.
BEGENT, ICRF, London and Department of
Medical Oncology, Charing Cross Hospital,
London.
A method of detecting circulating immune
complexes, which combines PEG precipita-
tion, adsorption to S. aureus protein A and
PAGE analysis of the fractionated material,
was used to screen sera of patients with
various types of malignant disease. To date,
differences from the control pattern of pro-
tein bands produced by PAGE offractionated
normal sera, have been most readily obtain-
able with the cases of Hodgkin's and some
other lymphomatous disorders. Judged by
electrophoretic mobility and serological reac-
tivity, an excess of apparently free immuno-
globulin light-chain (LC) is present in a num-
ber of these patients' sera during active
disease. Evidence will be presented showing
the tendency for serum LC to return to nor-
mal levels during clinical improvement due
to chemotherapy. This interesting relation-
ship warrants further investigations of the
potential value ofserum LC monitoring in the
clinical management of certain human
lymphomas.
THE Clq-BINDING TEST IN HUMAN
BREAST CARCINOMA. R. A. ROBINS,
P. J. DOYLE & R. W. BALDWIN, Cancer
Research Campaign Laboratories, University
of Nottingham.
Previous studies in this laboratory have
shown that the results of Clq-binding tests
using plasma samples from primary breast-
carcinoma patients correlate with other prog-
nostic indicators, and outcome of disease at
2 years after mastectomy (Hoffken et al.
(1978) Lancet, i, 672). Subsequent tests with
serum samples have shown much lower levels
of Clq-binding activity, and we have there-
fore investigated the influence of the method
of sample collection on the results of Clq-
binding tests. These studies have shown that
the presence of heparin (used in our earlier
plasma samples) results in a marked increase
in Clq-binding activity of pathological serum
samples, with little increase in control serum
samples from healthy individuals. The pre-
sence of heparin also increases the Clq-
binding activity of low, levels of aggregated
IgG. This modification ofthe Clq-binding test
allowrs a clear difference between patients and
controls to be demonstrated, and may be
useful in determination of prognosis in
primary breast carcinoma.
LOCAL B-CELL IMMUNE RESPONSE
IN BREAST CANCER; RELATION-
SHIP WITH PRESENCE OF THOM-
SEN-FRIEDENREICH-ANTIGEN (TF).
G. G. KONORZA, P. MULLER, P. J. KLEIN &
G. R. F. KRUEGER, Pathology Institute,
University of Cologne, WVest Germany.
The role of B-cell-mediated immune re-
sponse in tumour patients is unclear. This
study attempts to correlate the amount and
type (monoclonal/polyclonal) of Ig produced
in the local inflammatory infiltrate around
mammary ca. and in the regional lymph
nodes wvith the presence of TF antigen on the
tumour cells.
Routinely processed sections were ex-
amined in 19 cases, both tumour and lymph
node. TF antigen was determined with
marked lectins according to the method of
Klein et al., 1978 (Klin. Wochenshr., 56, 761).
Local and lymphnode Ig production (8-,u-,
A-, K-, chains in lymphoplasmocytoid cells)
wN-as assessed by immunofluoresence according
to the method of Denk et al., 1976 (Bietr.
Path., 159, 219). It was found that Ig produc-
tion is highest in differentiated carcinoma and
here is mostly monoclonal. However, the
amount of TF antigen correlates with the
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amouint of Ig only in cases with a low or
moderate expression of TF. Six cases with
most Ig production showied little or no TF,
the Ig synthesis being monoclonal in all 6.
This suggests the existence ofa strong antigen
other than TF, the possibility of the "shed-
ding" of TF-antibody complexes being an
alternative, as shown by Nordquist et al.,
1977 (Science, 366, 197) for other breast-
cancer antigens. This possibility is supported
by the findings of demonstrable amounts of
Ig on tumour cells in one of these 6 cases.
THE HISTOGENESIS OF NON-
HODGKIN LYMPHOMAS ASSESSED
BY SURFACE MARKING. J. A. HABE-
SHAW & A. G. STANSFELD, ICRF Medical
Oncology Unit, and Department of Pathology,
St Bartholomew's Hospital, London.
Surface marking of non-Hodgkin lymph-
omas showNs that the phenotype of the
neoplastic population corresponds to the
phenotype ofnormal lymphocytes at different
stages of differentiation. Both B and T
lymphocytes are derived from a common
stem cell which expresses ALL and Ia anti-
gen. Tumours of this cell are rare (30o) and
are always associated with ALL. Immature
T-cell tumours have the phenotype HTLA+
E rosette+, and are TdT-enzyme positive.
They form 40o of non-Hodgkin lymphomas.
Subsets of mature T cells express receptors
for IgG(Fc) and IgM (Ty and T1. cells). In
lymphomas, additional subsets of phenotype
E+C3+ and E+Fc+IgM+C3+ have been identi-
fied and form 30o ofNHL. The pre-B cell has
cytoplasmic immunoglobulin (CyIg) but no
surface immunoglobulin (Slg). It matures by
an antigen-dependent pathway in marrow to
the "virgin" immunocompetent B cell of
Slg+Fc+IgM+C3+ phenotype acquiring Fe
receptor (Slg+Fc+IgM+) before C3 receptor
(Stg+Fc+IgM+C3+). These phenotypes are
only seen in CLL and in DWDL and form
11% of lymphomas. Subsequent differentia-
tion is antigen dependent and is characterized
by the formation of follicle-centre cells
(Slg+C3+). Memory cells (Slg+Fc+C3+),
plasma-cell precursors (SIg+CyIg+) and
immunoblasts (non-capping Slg+) are de-
rived from the follicular cell. The phenotype
Slg+C3+ was found in 30%o of cases. Non-
capping Slg+ cells formed 14% of lymph-
omas (mainly DHL) and pro-plasma cells
18% of lymphomas (DPDL). Memory B-cell
tumours formed 70o of lymphomas (DPDL).
700 of lymphomas were formed of mixtures
of B and T cells. The conclusion is that most
non-Hodgkin lyinplhomas (7900) are derived
from reactive lymphoid populations, and sug-
gests that abnormal immune responses to
undetected antigens are the major patho-
genetic mechanism in lymphoma production.
REED-STERNBERG CELL/LYMPHO-
CYTE INTERACTION. A NON-SPECI-
FIC ADHERENCE PHENOMENON. S. V.
PAYNE, D. G. NEWELL, D. B. JONES & D. H.
WRIGHT, University Department ofPathology,
Southampton 3Medical School, Southampton
General Hospital
The dynamic interaction of T lymphocytes
with the surface of isolated Reed-Sternberg
(RS) cells may represent the immune T-cell
attack on RS cells which has been postulated
to be a central event in Hodgkin's disease
(Order & Hellman (1972) Lancet, i, 571).
Ultrastructural studies have shown that
this lymphocyte attachment ranges from
point contacts by lymphocyte mierovilli to
close apposition of large areas of the two cell
membranes, some stretches being regularly
spaced at 10-15 nm apart. There were no
membrane fusions, junctions, specializations
of the underlying cytoplasm or lymphocyte
invaginations, and no evidence of ultra-
structural damage to the RS cells. RS cell/
lymphocyte clusters may persist for 5 weeks
in culture without loss of viability. Pharma-
cological studies have shown that this inter-
action is dependent on intact surface proteins
(on both the lymphocytes and RS cells) and
on divalent cations. It is independent of
temperature, cell metabolism, intact micro-
tubules and microfilaments and protein
synthesis.
These features indicate that the attached
T cells are not cytotoxic, and that this is a
non-specific interaction unrelated to antigen-
dependent immune adherence.
CLASS-SPECIFIC ANTIBODY RES-
PONSES TO SURFACE ANTIGENS
OF HERPES-INFECTED CELLS, IN
PATIENTS WITH ABNORMAL CER-
VICAL CYTOLOGY. AND PATIENTS
WITH HERPETIC INFECTION.
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L. MENDIS, J. M. BEST & J. E. BANATVALA,
Department of Virology, St Thomas' Hospital
and Medical School, London.
An indirect immunofluorescence test was
used to detect IgG and IgA antibodies to
surface antigens of cells infected with herpes
simplex virus Type 2 (HSV-2). Sera were
obtained from patients with invasive car-
cinoma from England, Malawi, Sri Lanka and
Sudan, and from patients with dysplasia and
carcinoma in situ from England. A signifi-
cantly greater proportion of patients in all
groups had IgA antibodies when compared
with matched controls. There was also a
marked geographical variation in both IgG
and IgA antibody titres. IgA antibody titres
in patients with abnormal cervical cytology
from England were similar to those of
patients with genital herpes (HSV-2) and
were higher than those ofpatients with other
malignancies. Other workers have reported
no significant difference in the IgA titres to
the intracellular virus-capsid antigen of
HSV-2-infected cells between patients with
invasive carcinoma and controls. Serial serum
samples collected before and after radio-
therapy showed a significant rise in geo-
metric mean titre (GMT) of IgG antibodies
and a fall in the GMT of IgA antibodies,
although 4 patients from Malawi who were
treated by hysterectomy showed no change
in antibody titres. When sera were tested
from patients with facial herpes (HSV-1) and
genital herpes, the IgA antibody response
appeared to be more type-specific than the
IgG response.
MONOCYTE COMPLEMENT RECEP-
TORS AND LUNG CANCER. E. J. GLASS
& A. B. KAY, Department of Pathology,
University MedicalSchool, Edinburgh.
Chemotactic factors enhance the expression
of complement receptors on human leuco-
cytes, i.e. they produce an increase in the
percentage of leucocytes which form rosettes
with complement-coated red cells ("comple-
ment receptor enhancement"). The pheno-
menon was originally described with eosino-
phils and eosinophil chemoattractants
(Anwar & Kay (1977) Nature, 269, 522).
Recently we have shown that complement
receptors on neutrophils and monocytes were
similarly enhanced. For instance, casein, a
monocyte chemoattractant, enhanced mono-
cyte C3 receptors in a dose- and time-
dependent fashion. We have also studied the
capacity of dialysates from human lung-
cancer homogenates to inhibit enhancement
of monocyte complement receptors ("en-
hancement-inhibition"). All the tumour-
derived material so far examined produced
"enhancement-inhibition" (4 undifferenti-
ated, 4 squamous and 4 adenocarcinomas).
The effects of the tumour-derived material
were significantly greater than that ofnormal
lung distant from the tumour. Preliminary
studies suggest that the activity present in
lung-cancer homogenates giving "enhance-
ment-inhibition" is associated with a mol. wt
of - 8000. These results support theviewthat
tumours elaborate factors which inhibit their
interactions with monoiuclear phagocytes,
an intimacy thought to be of importance in
tumour surveillance (Supported by the
Cancer Research Campaign)
SURFACE AREA AND GROWTH CON-
TROL. C. H. O'NEILL, Imperial Cancer
ResearchFund, London.
A programmable calculator with digitiser
input can be used to measure the exposed
surface area of cultured cells, neglecting the
small folds and projections which are not re-
solved by the light microscope. We have
found that this area is related to serum con-
centration. Hamster fibroblasts show a 4-fold
reduction in exposed area as the serum con-
centration is increased from 5% to 66%. At
the higher concentration the mean exposed
area ofthese cells is equal to the surface area
of spherical cells, such as are seen in suspen-
sion culture. We have also found that the
transition probability (a measure of growth
rate) is more than 10 times greater in attached
cells than in suspended cells, in 5% serum. At
a serum concentration of 66%, the probabili-
ties in attached and suspended cells become
equal. It seems possible, therefore, that the
only important difference between attached
and suspended cells is the area of the surface
exposed to the medium. Suspension inhibi-
tion, like density-dependent inhibition, may
be a simple consequence of the rate of diffu-
sion of serum growth factors.
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CYTOSKELETAL ELEMENTS AND
GROWTH CONTROL: EFFECTS OF
CYTOCHALASIN AND COLCHICINE
ON 3T3 CELLS. G. D. CLARKE and P. J.
RYAN, Imperial Cancer Research Fund,
London.
BALB/c and Swiss 3T3 cells showr an 8-fold
difference in sensitivity to inhibition of DNA
replication and thymidine-labelling index by
cytochalasin B. They show a similar relative
sensitivity to reduction in exposed surface
area by the drug. These results, and observa-
tions of interacting effects of cell density,
cytochalasin B and colchicine on BALB/c
3T3 cells, may be explained in terms of the
exposed-surface-area model of growth con-
trol.
The involvement of microfilaments and
microtubules in growith-control processes may
be to alternatively restrict or optimize the
exposed surface area of a cell and thus its
interaction with macromolecular growth
factors.
INTERCELLULAR JUNCTIONS IN
METHYLNITROSOUREA (MNU)-IN-
DUCED CARCINOMA OF THE RAT
URINARY BLADDER. N. J. SEVERS &
R. M. HICKS, Cell Pathology Unit, School of
Pathology, Middlesex Hospital Medical School,
London.
Alterations in intercellular junctions are
associated with neoplastic transformation,
and have been implicated in some of the
biological properties of tumour cells (Wein-
stein et al., 1976, Adv. Cancer Res., 23, 23).
Using the freeze-fracture technique, we have
investigated tight junction and nexus struc-
ture in normal Wistar rat urothelium, and in
transitional-cell tumours Stage P1 (WHO
classification) induced by intravesicular in-
stillation of MNU. In normal urothelium, the
zonula occludens consists of a network of 3-5
interconnecting fibrils encircling the apical
lateral border ofeach superficial cell. Tumour-
cell tight junctions have a markedly variable
morphology; some are well developed and ex-
panded to twice the normal width, whereas
others are fragmented and may consist of
only a few short isolated ridges. This change,
also reported in FANFT-induced tumours
(Merk et al., 1977, Cancer Res.. 37, 2843) may
contribute to increased epithelial perme-
ability. Maculae occludentes and composite
occludens-nexus junctions are present deep
within neoplastic but not normal urothelium.
Two forms of nexus occur in normal tissue
Type 1, composed of closely packed intra-
membrane particles (IMP), and Type 2, con-
sisting ofless compact larger IMP. In contrast
to Pauli et al. (1977, Lab. Invest., 37, 609) we
find both forms in tumours, although Type 1
does occur with greater frequency than in
normal urothelium. These results suggest
that in bladder cancer, abnormalities in
growth control cannot be attributed to
absence of nexuses. However, if differences in
nexus morphology reflect functionally un-
coupled and coupled states, the predominance
of the Type 1 nexus in tumours might still
indicate impairment of intercellular com-
munication.
MORPHOLOGY AND SURFACE PRO-
PERTIES OF STEROID-RESPONSIVE
AND UNRESPONSIVE MAMMARY-
TUMOUR CELLS IN CULTURE. J.
YATES & R. J. B. KING, Imperial Cancer
Research Fund, London.
Cloned mouse mammary-tumour cells
maintained in testosterone-containing
medium (+A cells) show a proliferative re-
sponse to androgens which is lost after 3-5
weeks of culture in the absence of testo-
sterone (-A cells). Cytoplasmic and nuclear
androgen receptors are present in the -A
cells. The +A cells are fibroblastic in appear-
ance, grow to high cell density forming multi-
layered foci and are able to grow in suspen-
tion. In contrast, -A cells are epithelial and
grow only as a monolayer. They show a
higher rate of 2-deoxy-D-glucose uptake and
a greater sensitivity to serum concentration
than +A cells. Plating efficiency of +A but not
-A cells is diminished by concanavalin A.
Scanning electron microscopy shows marked
changes in the appearance and growth
pattern of the cells after hormone depriva-
tion. The morphological changes are being
correlated with the loss of hormone respon-
siveness and changes in biochemical para-
meters.
EFFECT OF GLUCOCORTICOIDS ON
HUMAN ASTROCYTOMA: CELL AT-
TACHMENT PROLIFERATION AND
TERMINAL CELL DENSITY IN VITRO.
R. I. FRESHNEY, D. MORGAN, M. HASSAN-
485I.C.F.R. AND B.A.C.R. JOINT SYMPOSIUM
ZADAH, M. BLACKIE & A. SHERRY, Beatson
Institute for Cancer Research, Bearsden,
Glasgow G61.
Stimulation of cloning efficiency and clonal
growth was demonstrated when colonies were
small, and w-as accompanied by a nmore com-
pact colony morphology, implying greater
cell-cell and cell-substrate adherence. When
colonies reached 1000-2000 cells proliferation
was reduced in treated colonies, producing
greater uiiiformity in colony size than in
controls, where a minority of colonies grow
to a larger size than treated colonies.
Glucocorticoids reduced the lower terminal
cell density of high-density multilayers and
reduced incorporation of 3H-thymidine and
lowered the labelling index. It appears that
one effect of glueocorticoids on glioma is to
promote cell adhesion and proliferation at
initiation of clonal growth, but subsequently
the effect on a high-density population is
cytostatic.
Since glucocorticoids may stimulate cell
adhesion by inducing synthesis of cell-surface
glycoprotein, this may have led to better cell
attachment and spreading, resulting in in-
creased proliferation at low cell densities,
while at high cell densities, density limitation
of cell proliferation may be enforced by in-
creased cell-cell adhesion.
THICK HYALURONIDASE-SENSITIVE
COATS ON TUMOUR CELLS. W. H.
MCBRIDE & J. B. L. BARD, Bacteriology Dep-
artment, Edinburgh University Medical School
& MRC Clinical & Population Cytogenics
Unit, Western General Hospital, Edinburgh.
A variety of adherent sarcoma, carcinoma
and normal cells are surrounded by thick
coats in vitro (around 9 ,um thick) that can
prevent spleen cells, as well as a variety of
other cells and particles, from coming near to
the cell membranes. This was obvious from
thepresenceoflargetransluscent halos around
the cells, which the indicator particles could
not enter. Seven lymphoblastoid cell lines
failed to show halos.
The presence of the thick coats of fibro-
sarcoma cells appeared to protect these cells
from lymphocyte-mediated cytolysis. Hyal-
uronidase treatment, which destroyed the
halo and allowed lymphocytes to approach
the tumour-cell membrane, enhanced the
cytotoxic action of immune but not of
normal spleen cells. These findings may be
relevant to the in vitro and in vivo killing of
tumour cells by immune effector cells.
SURFACE PROPERTIES OF LYM-
PHOID CELLS IN SPONTANEOUS
RETICULUM-CELL SARCOMA (RCS)
FROM SJL/J MICE. F. ROBERT & F.
DUMONT, INSERM, Unit of Experimental
Cancerology and Radiobiology, Vandoeuvre-
les-Nancy, France.
SJL/J mice spontaneously develop RCS in
abdominal lymph nodes. Studies on trans-
planted RCS have shown that the tumour cells
carry Ia3 antigen and exert stimulatory
activity upon syngeneic T cells in vitro
(Ponzio et al., 1977, J. Exp. Med., 146, 132).
However, little is known ofthe cellular events
which occur inprimary lesions. As an attempt
to monitor the histogenesis of such lesions,
we have investigated the electrokinetic
(surface charge) and antigenic properties of
individual cells from mesenteric lymph nodes
(MLN) during the development of spon-
taneous RCS in 10-14-month-old SJL/J mice.
In the early stages of MLN enlargement a
bimodal electrophoretic distribution was
regularly observed, with a low mobility (LM)
peak corresponding to SIg+, Ia+, Thy 1-2- B
cells (35%/) and a high mobility (HM) peak
corresponding to Thy 1-2+, SIg-, la- T cells
(65%). As the cellularity of MLN increased,
there was first an increase, then a decrease in
the frequency of LM cells. In the ultimate
stages of MLN hypertrophy, the bimodal
pattern was replaced by a single electro-
phoretic peak in the HM region. Size analysis
revealed the existence of at least 2 physical
types of cells with lymphoid morphology.
Population 1 which was predominant (80%)
and had a modal volume of 165 ,um3, was
characterized asThy 1-2+, Lyt 1-2+, las- and
slg-. Population 2, of lowest surface charge
(intermediate between typical B- and T-cells)
had a modal volume of 300-350 jum3. This
latter population, which was Ias+ and slg-,
was found markedly enriched in a transplant-
able RCS line grown in vitro and thus proba-
bly represents malignant elements. These data
suggest that MLN hypertrophy in primary
SJL/J lymphoma mainly results from a
massive in situ proliferation of Lyt 1-2+ T
cells possibly reflecting an auto-immune reac-
tion against Ias+ malignant cells.
(Supported by Ligue Nationale Fran9aise
Contre le Cancer.)
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